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Abstract 
In recent years, three-dimensional (3D) in vitro cell culture models such as spheroids and 
organoids have revolutionized life science research by providing a much more reliable context 
resembling the in vivo microenvironment. These systems yield important cell-to-cell 
interactions and induce cell differentiation. However, no conventional microscopy setup can 
provide sufficient imaging throughput as well as spatial and temporal resolution to enable full 
3D live imaging and analysis down to subcellular processes.  
In this project, we established state-of-the-art light sheet microscopy for live, long-term 
imaging of a short interfering ribonucleic acid (siRNA) treated 3D cell culture model. Due to 
the high temporal and special resolution of the light sheet microscope, we minimized imaging 
artifacts and achieved unprecedented visual representations of spheroids throughout 
development and upon gene knock-down by siRNAs. Furthermore, we deployed a high-
throughput image analysis pipeline and machine learning classification to evaluate global, 
cellular and subcellular features for a precise, quantitative gene knock-down phenotype 
description. The RNA interference (RNAi) induced gene knock-down phenotypes were 
replicated and compared by a novel molecular, site-specific epigenome modifying method.  
Throughout this project, we carefully evaluated every step of the workflow to improved its 
throughput and increased its reproducibility and usability. We addressed the key challenges 
in light sheet microscopy, such as sample preparation, data handling, image processing and 
analysis, thereby establishing quantitative light sheet microscopy screening of 3D cell culture 
models for many research applications. In total, we believe that our workflow can provide the 
basis for high-content analysis of 3D cell culture models for future research, enabling much 
more detailed functional experiments and basic research studies.  
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Zusammenfassung 
Dreidimensionale (3D) in vitro Zellkulturmodelle wie Spheroide und Organoide haben in den 
letzten Jahren den Bereich der Lebenswissenschaften revolutioniert, da sie die zelluläre 
Mikroumgebung in einem deutlich verlässlicheren Kontext wiederspiegeln In diesen 
Zellkulturmodellen können wichtige Zell-Zell-Kontakte ausgebildet und die Zelldifferenzierung 
induziert werden. Dennoch können etablierte Mikroskopie-Methoden bisher keine 
ausreichende Aufnahmegeschwindigkeit erzielen und weder die räumliche noch zeitliche 
Auflösung liefern, um vollständige 3D Aufnahmen und Bildanalyse von sub-zellulären 
Prozessanalysen zu ermöglichen. 
In dieser Arbeit haben wir die neuste Lichtblattmikroskopie für Langzeitaufnahmen von einem 
lebenden 3D Zellkulturmodellen nach einer Behandlung durch siRNA (kleine eingreifende 
Ribonukleinsäure) etabliert. Durch die hohe zeitliche und räumliche Auflösung des 
Lichtblattmikroskops konnten wir Mikroskopieartefakte minimieren und erzielten bisher 
unerreichte visuelle Darstellungen von Spheroiden sowohl während ihrer Entwicklung, als 
auch nach Verminderung der Expression spezifischer Gene durch siRNA Behandlung. Für die 
präzise und quantitative Beschreibung von Phänotypen, die durch die Herunterregulation 
bestimmter Gene hervorgerufen wurde, haben wir eine Hochdurchsatzbildanalyse-Pipeline 
sowie Klassifizierungen mittels künstlicher Intelligenz zur Bewertung von globalen, zellulären, 
sowie subzellulären Eigenschaften etabliert und verwendet. Außerdem wurden die 
interferierende RNA induzierten Phänotypen mittels einer neuen molekularen, zielgerichteten 
Methode zur Modifizierung des Epigenoms repliziert und verglichen. 
Während der gesamten Projektes haben wir jeden Schritt des Arbeitsablaufs kritisch evaluiert 
um Durchsatz, Reproduzierbarkeit und Verwendbarkeit zu verbessern. Die 
Schlüsselprobleme der Lichtblattmikroskopie wie Probenvorbereitung, Datentransfer, 
Bildbearbeitung und Bildanalyse konnten wir durch einen hohen Grad an Automation von der 
Zellpertubation bis hin zur abschließenden Analyse beheben. Dadurch haben wir ein 
quantitatives Lichtblattmikroskopie-Screening von 3D Zellkulturmodellen für weitreichende 
wissenschaftliche Anwendungen etabliert. Insgesamt glauben wir, dass unser Arbeitsablauf 
die Basis für eine Hochdurchsatzanalyse von 3D Zellkulturmodellen für zukünftige 
Forschungsprojekte bereitstellen kann, da er detailliertere funktionale Analysen ermöglicht. 
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1 Introduction 
Naturally arising oxidative damage to the human genome occurs around 10,000 times per day 
in every single cell [1]. Due to DNA repair mechanisms or induced cell death, these mutations 
do not have a detrimental effect on the tissue [2] or organism. Yet, if these mechanisms fail, 
mutations are acquired over time and can induce uncontrolled cellular expansion, resulting in 
cancer development. Growth and spreading of cancer tissue into essential organs can result 
in organ failure and patient death [3]. Today, cancer is still one of the leading causes of death 
despite medical improvements in recent years in developed countries [3]. To understand how 
cancer develops, how it spreads, and how it can be cured, cancer research has to study the 
underlying cellular mechanisms inducing cancer development, and how these changes can 
be reverted, or how cancer tissue can be specifically treated to inhibit cellular growth. Novel 
3D human cell culture models provide a versatile system to study cancer development, tumor 
remission, as well as potential treatments [4].  
 
1.1 Cell culture models in cancer research 
Human and animal cell culture models are an essential, irreplaceable component in any life 
science research from basic research to translational cancer research [5, 6]. The term cell 
culture model refers to living, immortalized cells that live and proliferate under defined culture 
conditions (Figure 1). Cell lines can be established from tumor or somatic tissue [7]. 
Immortality can be acquired through naturally occurring mutations in tumor tissue or through 
introduction of a viral gene or modulated gene expression that deregulates the cell cycle [8]. 
Cell lines resemble properties of the tissue of origin, while xenografts in mice are a common 
method to improve tumor resemblance of the cell line as patient-derived xenografts 
accumulate copy number alterations due to selection of minor clones (Figure 1) [9].  
Cell lines facilitate the study of cellular components, properties, processes, and functional 
responses to internal and external cues in a simple, robust, and easy-to-use setup with many 
established imaging and omics analysis methods. These omics methods allow evaluation and 
quantification of different aspects of RNA and protein biosynthesis, function, localization, 
homeostasis as well as their dynamics (Figure 1) [4, 10, 11]. 
Throughout history, these cost-effective in vitro cell cultures have led to significant insights 
into biological processes, circumventing elaborate work with model organisms as well as 
enabling studies on live human tissue [12]. One of the greatest advantages of cell culture 
research is the abundancy of different cell lines and the possibility to rapidly enlarge sample 
size and the number of cells. Additionally, many methods have been established to modify the 
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genome or transcriptome and to generate transgenic cell lines that express, for example, a 
recombinant protein or lack an endogenous gene of interest. 
 
 
Figure 1 – Cell culture models for molecular and phenotypic analysis 
purposely immortalized with viral genes and subsequently expanded in defined growth media, ensuring high 
proliferation and defined cell characteristics through culture media supplements. An additional step of mice 
xenografts improves viability and tumor properties of the cells. Established cell lines can subsequently be used in 
2D or 3D environments for functional experiments analyzing structural features by immunofluorescence (IF), or 
molecular properties by fluorescent in-situ hybridization (FISH). Functional and omics methods characterize the 
genotype and phenotype of the tissue of origin. 
 
1.1.1 2D cell culture – a basic in vitro model systems for research 
For many decades, two-dimensional (2D) cell culture models have been the state-of-the-art 
system for any in vitro study, even though the physiologically relevant microenvironment is 
missing. In 2D, cells are usually grown on a stiff plastic surface, covered by their respective 
culture medium and passaged every few days, depending on their replication time. The hard 
surface of the culture dish modifies tissue-specific cell architecture and forces a defined 
polarity and cell shape onto the single cells, which alters mechanical and biochemical signals 
and subsequent cell-to-cell communication [13]. Modern alterations of 2D systems like 
transwell polycarbonate membrane cell culture inserts allow for more complex cultivation, as 
for example reconstituting the air-tissue interface of the lung [14]. 
Different implementations of 2D cell culture have helped extensively to understand cellular 
properties, though lacking the 3D context of the in vivo tissue [6, 12, 13]. Important cell-to-cell 
interactions between cells or the extracellular matrix (ECM) are also absent. Differentiation 
inducing or retaining physical microenvironment properties are lacking. Yet, these non-
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physiological culture properties influence gene expression profiles and therefore the 
phenotype of the cells [15]. 
Due to these non-physiological culture conditions, cells grown in monolayer can lose distinct 
properties and features that are potential drug targets in medicine. For instance, primary 
hepatocytes cultured in 2D lose their differential state within a few days and monolayer cells 
silence drug component metabolizing enzymes, which makes 2D models much more sensitive 
to drugs [16]. Administering the same drug concentration that was effective in a 2D cell culture 
model to a patient, it would be highly inefficient and potentially even induce drug resistance in 
the cancer tissue [7]. 
Last but not least, a surrounding tissue can influence availability of nutrition and oxygen, 
limiting the cellular metabolism and replication time, introducing cell differentiation [13, 17] as 
well as influencing the drug permeability to the target cells [7].  
 
1.1.2 3D spheroid cell culture in life science research 
Most of these above mentioned major drawbacks of 2D cell culture models are addressed by 
the application of 3D cell culture models in research, first used in the late nineteen-fifties [18]. 
Today, there are two established nomenclatures for cultured 3D cell clusters – spheroids and 
organoids. While these two 3D cell culture systems differ in size and progress of differentiation 
of single cells within the cluster, but attributes that define the transition from a spheroid to an 
organoid are not clearly outlined and subject to ongoing discussions.  
There is a great variety of tested and continuously improving methods to induce 3D spheroid 
development. Mechanical solutions like the “hanging drop”, “ultra-low attachment plates”, 
“spinner flask culture” or the “rotary cell culture system” [19] do not allow any adhesion of cells 
to a surface and therefore cause cells to aggregate. Other approaches reconstitute the basal 
membrane through a gelatinous protein mixture called Matrigel derived from Engelbreth-Holm-
Swarm mouse sarcoma cells. Matrigel contains essential ECM proteins such as laminin, 
collagen IV, heparin sulfate proteoglycans, entactin or nidogen and a number of selected 
growth factors [12, 13].  
Results obtained from research using 3D cell culture models like spheroids have shown that 
the additional dimension and loss of stiff culture surface changes gene expression 
dramatically, thus resembling more closely the respective (tumor-) tissue [7, 20]. Furthermore, 
key events of cellular development, such as proliferation, migration and induced apoptosis are 
defined by the extra cellular context [17, 21, 22], which means that essential factors and 
physical properties of the ECM need to be established throughout spheroid development, 
simulating the in vivo context. Another strong point for the usage of 3D cell culture models is 
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the high degree of heterogeneity between the cells due to differentiation and sub-type 
development [23], as it can be found in tumor tissue. It was shown by Ghosh and colleagues 
that genes upregulated in tumors match with their gene expression in their respective 3D cell 
culture model [20]. The close imitation of in vivo tissue improves reliability and reproducibility 
of research results, and therefore closes the gap between cell culture and the respective 
physiological in vivo tissue [24]. 
Especially in the field of oncology and the selection of promising drugs in pre-clinical screens, 
the discussed advantages of 3D cell culture models [5] provide the essential context for the 
characterization of cancer subtype and its therapeutic treatment [7, 22].  
 
1.1.3 Tumor initiation 
Cancer development describes a process of successive accumulation of (epi-) genome 
mutations that alter the gene expression profile of a cell and thereby cause this cell to undergo 
an abnormal phenotypic transformation with acquisition of biological capabilities [9, 25]. Post-
mitotic somatic cells can reacquire stem cell like properties re-entering a highly proliferative 
state and invade into other tissues or organs, where the misallocated cells can cause organ 
failure through growth and nutrient deprivation of the physiological tissue [25, 26]. The general 
theory implies that a single mutation is most of the time not sufficient to induce cancer 
development, but it is rather the interplay of accumulated mutations, which change the cell’s 
gene expression. Genes regularly activated in this process are called oncogenes, while genes 
which often repressed throughout oncogenesis are called tumor suppressor genes [27-29].  
Tumor tissue can be separated into two states, benign and malignant [23]. Benign tumors 
remain at the original tumor site and have not (yet) acquired the capability to invade 
neighboring tissue, while malignant tumors are able to migrate and invade other body parts 
[29]. Both groups can show a high degree of cell proliferation, a key hallmark of cancer [25]. 
Further cancer hallmarks include genome instability, evasion of growth suppression and 
immune destruction including apoptosis resistance, replicative immortality, reprogrammed 
metabolism, induced angiogenesis in the tumor tissue, and invasive migration capabilities [5]. 
 
1.1.4 The role of mitotic defects in tumorigenesis 
Cell division or mitosis is a highly regulated, cellular process describing the replication and 
separation of the full genome into two daughter cells, which is a prerequisite for life and growth 
of any organism. The cell cycle can be divided into different stages or phases that separate 
the replicated genome into the two daughter cells. During the prophase, the DNA is 
compacted into chromosomes with two identical sister chromosomes attached at the 
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centrosome and the nuclear envelope is being disassembled. The chromosomes are 
subsequently aligned at the mid plane of the cell during the metaphase with the help of the 
mitotic spindle apparatus. These microtubules are attached to the centrosomes and separate 
the sister chromosomes to one pole of the dividing cell during the anaphase. The cell division 
is completed during the telophase, when two daughter cells complete the cytokinesis, 
disassemble the mitotic spindles, decondense the DNA, and reform the nuclear membrane as 
well as acquire normal cellular shape.  
Numerous mechanisms such as the spindle assembly check point and the no-cut checkpoint 
control define steps of the mitosis and ensure accurate distribution of the genome to the 
daughter cells [30]. Minor mistakes throughout mitosis can result in daughter cells with an 
incomplete genome or too many chromosomes, a feature called aneuploidy. Aneuploidy is 
regarded as common trait of cancer cells, arising in almost 70% of solid human tumors, as 
chromosome misdistribution provides cancer cells with a mechanism to lose tumor suppressor 
loci and gain extra copies of oncogenes [31]. Furthermore, features of cancer cells include 
structural alterations such as genome region translocation, amplification or deletion, resulting 
from high proliferation and loss of DNA repair mechanisms. These traits are referred to as 
chromosomal instability and are a leading cause for tumor development [32], from initiation, 
to growth, and acquisition of additional cancer hallmarks. In total, mitotic defects are 
considered the most influential step in tumor initiation and subtype formation, resulting in 
intratumor heterogeneity [23, 33].  
 
1.1.5 Resolving intratumor and intertumor heterogeneity 
Intratumor and intertumor heterogeneity in genotype, epigenotype, phenotype, and underlying 
gene expression are conceived as the most crucial aspects that needs to be analyzed to treat 
cancer patients [23]. The heterogeneity among patients makes it challenging to decide on a 
defined treatment solely by the tumor type. Small differences in tumor initiation and 
progression can cause distinct phenotypes within a single patient and a single tumor, with 
various resistances to one or the other chemotherapy [23, 33-35]. Furthermore, depending on 
the tissue of origin and the tumor microenvironment, a single tumor type could display distinct 
properties [35], drug resistance [36] and relapse properties [37]. For example, although almost 
indistinguishable by histo-cytochemistry, the tumor medulloblastoma displays a high chance 
of remission when originating from the dorsal brainstem, while medulloblastoma arising in the 
cerebellum causes a much shorter life expectancy [38]. To tackle tumor heterogeneity, it is 
not only essential to establish analysis methods that allow a focusing on the individual cell in 
the context of a microenvironment. Furthermore, it is essential to establish 3D cell culture 
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models representing defined tissue characteristics that can be used to analyze the initial steps 
of tumor development as well as tumor progression.  
 
1.1.6 MCF10A – a benign breast epithelia model for tumor initiation studies 
One of the most commonly occurring cancer types for females is breast cancer. In the United 
States in 2017, women in the United States had a 12.4% (1 in 8) lifetime risk to be diagnosed 
with breast cancer [breastcancer.org]. There are two main groups of breast cancer described, 
the ductal carcinoma in situ and lobular carcinoma in situ also known as lobular neoplasia [39]. 
In both breast cancer types, epithelial cells acquire in a stepwise transformation a highly 
proliferative phenotype starting from local hyperplasia to premalignant carcinoma in situ and 
developing into the highly motile, invasive carcinoma [28]. Breast cancer cells invade and 
expand into the ducts and lobules of the breast. Causing mutations are highly probable in the 
BRCA1 and BRCA2 genes [2]. These tumor suppressor genes encode for nuclear 
phosphoproteins that play a key role in maintaining genomic stability by regulating the 
homologous recombination pathway for double-stranded DNA repair [2, 31, 40]. A defect in 
this repair system causes a high likelihood to acquire genetic mutations that cause the 
development of breast cancer.  
Michigan Cancer Foundation 10A cell line (MCF10A) is a benign, in vitro, human breast 
epithelium derived, 3D cell line that develops under 3D culture conditions in Matrigel into 
polarized micro tissue called spheroids [41]. These spheroids represent the acini of the human 
breast and display essential functions such as polarization and differentiation and exhibit the 
cell-to-cell variability found in the respective in vivo organ [12, 22]. These properties make the 
MCF10A cell line the ideal candidate for tumor initiation screens, in which the acquisition of 
(epi-) genetic mutations is replicated and reconstitutes the first steps of tumor development in 
vitro. 
 
1.2 Epigenetics 
Genetic and epigenetic mutations equally contribute to loss or gain of gene expression and 
oncogenic cell transformation [42, 43]. Epigenetics describe all non-genomic but heritable 
DNA modifications that are passed from the mother-cell to the daughter-cells [44]. The 
importance of aberrant DNA modifications and DNA associated protein modifications in 
tumorigenesis and tumor metastasis is highlighted by the increasing number of known tumor 
associated epigenetic alterations [45]. The two principal epigenetic modifications known for 
their significant role in cancer development are DNA methylation at 5-methylcytosine of the 
cytosine guanine dinucleotide (CpG) and covalent post-translational histone modifications 
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[46]. The latter include an addition or removal of a methyl group, acetyl group, phosphorylation, 
ubiquitination and sumoylation at the histone tails of the different subunits of the protein 
complex. And they are mediated by the enzyme group of histone modifiers and the chromatin 
remodeling complex [47-52]. The second main class of epigenetic modifications describes an 
addition of a methyl group to the cytosine of a CpG dinucleotide. Genomic regions that show 
distinct differential DNA methylation levels between tumor or non-tumor tissue at CpGs are 
called differentially methylated regions (DMR) and are regularly associated with CpG islands, 
DNA regions with high percentage (> 60%) of cytosine guanine dinucleotide and a length of 
at least 200 base pairs [53]. The DNA methyltransferase family (DNMT) catalyzes the addition 
of the methyl group to the C5 position of the cytosine ring (5-mC) in CpG dinucleotide. DNMT1 
preferentially binds to replication sites in the S phase and methylates hemimethylated DNA, 
maintaining the methylation pattern on the newly synthesized strand [54] (Figure 2a). DNMT3a 
and DNMT3b catalyze de novo methylation at loci throughout development of an organism or 
a tissue [55] (Figure 2a). DNMT3l is an important stimulatory factor for DNMT3A, which 
regulates the duration of the attachment of methyltransferases to the DNA [56]. 5-mC is a 
reversible DNA modification that can either be lost through semi conservative DNA replication, 
or through a multistep enzymatic process. The initial step of DNA demethylation is catalyzed 
by Ten-eleven translocation methylcytosine dioxygenase 1 (TET1), oxidizing the modified 
DNA base 5-methylcytosine to 5-hydroxymethylcytosine (5-hmC) [57] (Figure 2a). 5-hmC is 
then further processed to 5-carboxylcytosine (5-caC) which is subsequently excised by a 
thymine DNA glycosylase (TDG) generating an abasic site as part of the base excision repair 
(BER) process [58] (Figure 2a).  
 
1.2.1 Epigenetics in tumor development 
Epigenetic modifications at DMRs are able to significantly impact gene expression through 
rearrangement of the nucleosomes, changing the chromatin structure as well as allowing or 
inhibiting the binding of transcription factor and regulating the recruitment of histone modifiers 
(Figure 2b) [59]. DMRs are found mainly in promoter regions, but also in gene bodies and 
intergenic regions. Although not exclusive, hypermethylated DMRs generally correlate with 
gene repression, while hypomethylated promoters are associated with higher gene expression 
[53, 60]. 
 
1.2.2 Epigenome modifying molecular tools 
The fact that epigenetic states are in some genomic regions highly responsive to external 
influences or the cellular, developmental progress in a highly reproducible manner, make 
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epigenetic markers a more promising target for tumor therapy than genome modifications [61-
64]. Genomic locus directed epigenome modifying enzymes in theory allow a complete 
remission of the tumor state, reverting the oncogenic phenotype of the epigenome 
misregulated tumor cell [64] (Figure 2b). Furthermore, epigenome modifying molecular tools 
are able to induce a defined gene expression pattern that drives a cell into apoptosis or inhibit 
certain cancer hallmark phenotypes [65-68]. Epigenome remodeling enzymes have been 
described already in the 1990s, but the key challenge is the accurate positioning of these 
enzymes to a genomic locus for site-specific epigenome remodeling [64, 69, 70]. 
Several molecular tools have been developed over the last years, including Transcription 
Activator-Like Effector Nuclease (TALEN) [71], and zinc finger DNA binding proteins (ZF) [65, 
72] (Figure 2c). These systems have been successfully adapted to modify epigenetic traits at 
a specific genomic locus [49, 73, 74]. Most problematic for these methods were cost and effort 
required to generate a single functional epigenome modifier in relation to the epigenome 
modification success rate [75]. Each target site requires a redesign and protein synthesis of 
the ZF and TALEN with no guarantee of high effectivity [71].  
The clustered regularly interspaced short palindromic repeats (CRISPR) system, described by 
three groups almost simultaneously in 2012 [76-78] was adapted from its function as microbial 
adaptive immune system to a recently broadly used genome editing tool [76]. In the following 
years, the original CRISPR system was adapted to a broad range of additional applications, 
using the deactivated Cas9 (dCas9) to target specific effector domains (dCas9-ED) to a 
specific genomic locus (Figure 2c) [79-84]. In the dCas9 protein, the two endonuclease 
domains RuvC and HNH are mutated in a single residue each (D10A / H840A) [24], forfeiting 
the endonuclease activity of the molecular tool. The greatest advantage of the different al 
CRISPR systems is the high adaptability, since site specificity is defined by the RNA 
component, the single guide RNA (sgRNA), which can be administered separately to the 
dCas9 protein component [85, 86]. This trait enables a fast exchange of genomic targets and 
versatile synthesis. Furthermore, multiple genome sites can be targeted simultaneously [87-
89]. A drawback of the usage of the CRISPR-dCas system for locus specific epigenomic 
editing is the lower target specificity, which allows base pairing with up to 5 mismatches 
between sgRNA and the DNA [90] thus requiring cautious experimental design. Rapid 
development and constant improvement of online target selection and off-targeting prediction 
tools have made sgRNA synthesis and specificity evaluations a relatively easy task [87, 91, 
92].  
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Figure 2 – Gene regulation by methylome modification in tumor tissue 
a) The addition of a methyl group to 5C is catalyzed by DNMT1 (methylation pattern maintenance) or by DNMT3a/b 
(de novo methylation). DNA methylation is a reversible modification that can be actively removed by a multistep 
enzymatic reaction induced by TET1 catalyzing the initial step of demethylation b) Many tumor types are associated 
with aberrant DNA methylation on single CpGs or entire regions. Particular aberrant methylation pattern in DMRs 
of oncogenes and tumor suppressor genes result in tumorigenesis through abnormal gene expression. c) Zinc 
finger DNA binding proteins, TALEN, or CRISPR-dCas9 fused to methylome-modifyingifying enzymes have been 
shown to be functional in site directed methylome modification inducing selected transcription activation or 
repression. 
 
In the last three years, a number of epigenome modifying applications utilizing the CRISPR-
dCas9 system to site-specific epigenome editing have been published (Figure 2c). Hilton and 
colleagues achieved gene activation through histone H3 lysine 27 (H3K27) acetylation by 
fusing the acetyltransferase p300 core domain to the dCas9 [93], while Kearns and colleagues 
described a similar approach with gene repression through coupling of the LSD1 to the dCas 
and targeting H3K4Me2 and H3K27Ac histone modifications around the targeted Tbx3 
enhancer region [94]. Other epigenetic enzymes like KRAB, DNMT3A, and DNM3L and TET1 
also allowed for long-term epigenetic silencing or activation of the target endogenous genes 
through site directed methylation and demethylation of specified genomic regions [63, 95, 96] 
(Figure 2c). Although highly innovative, all these approaches display one common, crucial 
difficulty besides the methylome engineering efficiency. The alterations at the epigenome 
could be analyzed by methods such as pyrosequencing or ChiP-seq technology, but functional 
validations of the effect onto the cellular phenotype were not definite [52, 61, 93].  
 
1.2.3 3D context and epigenetics – a new challenge in cancer research 
Conventional methods like siRNA knock-down functional experiments and the described novel 
epigenome modifying tools can be used to study gene function, regulation, and individual 
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contribution to oncogenesis in 3D model systems. The contribution of the epigenome to 
tumorigenesis as well as the capability of the epigenome modifying molecular tools to precisely 
change these properties provide novel possibilities to revert cancerous characteristics of cells. 
Major challenges for this method are off-targeting effects, insufficient understanding of 
comprehensive regulatory mechanisms and effects of site directed epigenetic modifications 
[73]. The advantage of targeted epigenetic modification over traditional methods such as 
siRNA for a high-throughput knock-down screen needs to be determined, as CRISPR-Cas9 
based targeted epigenetic modifications require a protein component as well as a RNA 
component delivered into each cell to induce genomic site directed epigenome modification.  
Many analysis methods such as (epi-) genome and transcriptome sequencing, metabolism 
analysis and imaging are currently adapted, improved or developed to suite the requirements 
of 3D cell culture models. Especially difficult is the visual representation of the spheroid or 
organoid. Due to light scattering, conventional microscopy techniques such as epifluorescent 
or confocal microscopes are insufficient to visualize and analyze the entirety of these 3D cell 
culture models. Novel imaging techniques such as light sheet microscopy for the first-time 
facilitate full 3D acquisition of spheroids and organoids.  
 
1.3 Fluorescent light sheet microscopy 
To study subcellular processes, development, or interactions between cells of a tissue, light 
microscopes are the most important and powerful analytic tool, as they can resolve subcellular 
components smaller than one micrometer [97]. 
 
1.3.1 Fluorescent microscopy 
The development of the fluorescent microscope improved resolution and enabled a selected 
visualization of single structures and subcellular components. In a fluorescent microscope, the 
specimen is illuminated by a defined wavelength that is absorbed by the fluorophores [97]. 
These excited fluorophores emit the absorbed energy at a longer wavelength than used for 
excitation [98]. This shift between excitation and emitted wavelength is used to split the optical 
signal enabling fluorophore localization [97]. Fluorophores, such as dyes or fluorescent fusion 
proteins enable a visualization of cellular structures or components [99-102].  
Key fluorescent microscopy technologies available to almost all life science researchers are 
conventional epifluorescence microscopy (Figure 3a), confocal laser scanning microscopy 
(CLSM) (Figure 3b) and Spinning-disk (Nipkow disk) confocal microscopy (SDM). Today, 
many different advances in microscopy development such as super resolution microscopy, 
have pushed the resolution limit further, making cellular processes or structures visible that 
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could not have been observed otherwise [103]. Additionally, constant improvement of 
molecular staining tools such as fluorescently labeled antibodies, fluorescent dyes, and 
fluorescent tags for proteins [99] exemplified by the green fluorescent protein (GFP) [102] and 
its deviates, facilitate novel applications and methods.  
Although broadly established, conventional bright field and fluorescent microscopy have a 
substantial disadvantage as the excitation light illuminates the entire specimen, causing photo-
bleaching and phototoxic effects in all planes of the entire sample, while the emitted light is 
detected only in a single plane [104]. With the development of the light sheet microscope, the 
issue of redundant light overexposure of the sample is addressed [10, 104-106].  
 
1.3.2 Light sheet microscopy 
In 1903, Siedentopf and Zsigmondy described the very first concepts of a light sheet 
microscope [107]. The so-called “ultramicroscope” employed a slid aperture to project sun 
light onto a sample at a 90° angle to the detection objective. This setup illuminated only a thin 
section of the sample, providing lateral sectioning. Almost a century later, Voie and colleagues 
reimplemented the orthogonal orientation of excitation and detection path to image the internal 
architecture of the cochlea with their orthogonal-plane fluorescence optical sectioning 
(OPFOS) microscope [108]. Their microscope already comprised many features of today’s 
commercially available light sheet microscopes, such as laser excitation, beam expander for 
light sheet modulation, a cylindrical lens to generate the light sheet and Z-stages to move the 
specimen through the light sheet. Although acknowledged as innovative imaging technique, 
light sheet fluorescent microscopy (LSFM) remained largely unrecognized as method for life 
science research. In 2004, Jan Huisken and colleagues [109] published their single-plane 
illumination microscopy (SPIM) setup, which was capable to visualize in vivo muscles in a 
transgenic Medaka (Oryzias latipes) fish model organism as well as image development of a 
Drosophila melanogaster embryo for up to 17 hours at unmatched spatial and temporal 
resolution. 
Throughout the subsequent years, SPIM imaging was accredited as surpassing imaging 
technique [105] with superior properties to conventional microscopy, which caused a rapid 
development of many different light sheet technology implementations. Many research groups 
developed their own implementation of the optical setup to study mainly embryogenesis of 
different model organisms, focusing on tissue differentiation, organ development and cellular 
positioning throughout the development of the embryo [104].  
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1.3.3 Opto-physical principles of light sheet microscopy 
All light sheet microscopes are based on the same basic, opto-physical principles. But they 
highly differ in light sheet generation, in number and properties of the excitation and detection 
paths, as well as in the orientation of the setup [106, 110]. In comparison to any other 
fluorescent microscope, in which a single objective emits the excitation light along the same 
axis as the fluorescent signal is collected (Figure 3a-b), the light sheet microscope splits 
excitation and detection light path at a commonly 90° angle and illuminates the sample from 
the side (Figure 3c).  
 
 
Figure 3 – Overview on fluorescent imaging techniques 
Schematic (not drawn to scale) of microscopes acquiring a single image (red line) of a 3D spheroid sample. Insets 
describe illumination pattern needed for single slice acquisition. The specimen is illuminated with light at a 
fluorophore-specific excitation wavelength (blue). The fluorophores at ground state absorb the light energy and 
acquire an excitation singlet state. Immediately, fluorophores recover the stable ground state through energy and 
light emission at a longer emission wavelength detected through the detection path (green). Objectives, filters and 
dichroic beamsplitters direct and split the different excitation and emission wavelengths from the light source onto 
the sample and from the sample onto the detection apertures. a) In epifluorescent microscopes, the excitation light 
is transmitted through the sample, which allows for full frame detection, while in a confocal microscope b) the light 
is focused in a single point and scanned over time across the focus plane creating a scanned image. A pinhole 
(black disc) dismisses out-of-focus light. In both microscopes, excitation and detection optical path are passing 
through the same objective. c) In a light sheet microscope, excitation and detection paths are separated by 90°. 
Only a thin sheet of light or Gaussian beam is used to scan across the sample in synchronization with a full frame 
camera, illuminating only a thin layer of the sample per frame.  
 
The light sheet can either be generated by a collimated laser passing through a slit aperture 
and a cylindrical lens forming a static light sheet or a virtual light sheet can be generated by a 
Gaussian beam that is scanned by a Galvo scanning mirror across the field of view [4, 104, 
110-112]. Both technical implementations form a thin sheet of light that illuminates only a thin 
layer within the specimen, reducing the overall light exposure onto the sample drastically [104] 
and provide already a good sectioning of the sample (Figure 3c) [104]. The detection objective 
is placed at a perpendicular angle to the light sheet at focal distance, and transmits the 
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emission signal onto modern, full-frame scientific complementary metal-oxide-semiconductor 
(sCMOS) cameras [113]. 
From the most basic setup of a single excitation and secondary single detection objective, 
many novel implementations of the light sheet technology have evolved [110]. Some 
microscopes combine two detection and two excitation objectives orientated horizontally 
around a vertically placed sample, called a multi view setup [114]. This can be utilized to 
acquire four images of a specimen without rotation, each view acquiring a quarter of the 
sample at the highest resolution [114]. Another custom-built light sheet setup was developed 
to acquire mouse embryos at resolution limit [115]. Strnad and colleagues used an asymmetric 
setup with high numerical aperture (NA) detection objectives combined with a low NA 
excitation objective to acquire developing mouse embryos at the highest possible spatial 
resolution [115] while minimizing light exposure.  
 
1.3.4 Sample mounting in light sheet microscopy 
LSFM imaging requires a higher effort to prepare samples for imaging in comparison to 
standardized sample mounting for conventional microscopy with samples mounted on a 
simple glass slide or culture plate, making sample mounting one of the key challenges for 
SPIM imaging [10, 110, 116]. The optical geometry of a LSFM with two or more objectives at 
an extremely close proximity makes mounting and positioning the sample between the 
objectives an issue [114]. Furthermore, to obtain the optimal imaging conditions, it is essential 
that all components of the optical path and mounting media are adjusted to the refractive index 
(RI) of the sample [117]. Additionally, optimal environmental conditions like temperature, gas 
exchange, and nutrition must be provided without affecting light transition. Samples mounted 
in transparent fluorinated ethylene propylene (FEP) tubes and foils (Figure 4a), that have an 
RI of 1.33 identical to aqueous solutions ensure the continuity of the RI throughout the optical 
paths while also improving position and imaging stability [118, 119]. One major drawback of 
the usage of FEP foil is the reduced gas and nutrition exchange. Translucent gels like agarose 
and Matrigel are broadly used for aqueous imaging media and minimize light scattering (Figure 
4b-c), while constraining the sample to a defined position [10].  
Motorized positioning stages with extremely high precision and long travel range provide the 
capability to position the mounted sample exactly at the focal plane between the objectives for 
imaging. Larger samples with a size of 200 µm like developing embryos, plant roots or large 
organoids require additional imaging strategies like multi view acquisition to compensate for 
in depth light scattering [4, 109, 114].  
 
 14 
1.3.5 Sample acquisition and acquisition modes 
Jan Husiken et al. [109] were the first to implement a rotary stage that is capable of rotating 
the sample around an orthogonal axis and acquire the sample at multiple angles (Figure 4a). 
Only one excitation and one detection optical path, as exemplified in Figure 3c and Figure 4a, 
are needed for multi view imaging, but multiple excitation and detection paths can reduce 
imaging time.  
Another approach for multi view acquisition, circumventing the rotation of the sample, is the 
usage of multiple, alike excitation and detection paths at either a 90° or 180° angel [112, 120]. 
For these light sheet microscopes, we can distinguish between two distinct imaging techniques 
to acquire a volume (Z-stack) of the specimen. With stage scan acquisition (SSA), the sample 
is translated through a static light sheet. On the one hand, SSA is advantageous for larger 
samples, because less optical components need to be adjusted which reduces vibrations and 
component cost, but on the other hand it is prone to produce excessive single view data for 
smaller samples (Figure 4b). Stage scan acquisition does not require an additional piezo motor 
moving the detection objective in sync with the light sheet. But it relies on a constant, 
uninterrupted and precise movement of the stage, translating the sample through the light 
sheet. SSA is furthermore challenging for image processing as the acquired data is skewed 
when the sample translation is not at an orthogonal angle to the excitation axis (Figure 4b) 
[121]. XY pixel positions do not directly correlate between slices in a Z-stack. And finally, to 
image a volume at multiple views, the Z-stack limits have to be set outside of the field of view 
(FOV), to ensure the acquisition of the FOV from each angle. 
The second method is synchronous piezo/slice acquisition (SyncA) (Figure 4c). Here, the 
stage is stationary, while the light sheet is translated at focal distance in a synchronous 
movement together with the detection objective through the Z-stack [121, 122]. In comparison 
to SSA, SyncA requires more optical components to be adjusted like the position of the 
detection objective and the Z-position of the light sheet [112]. At these small intervals high 
frequency movements cause vibrations, and therefore elongate the minimal time between 
acquisitions of each slice of the Z-stack. However, only a defined volume is acquired from two 
views, restricted by the imaging properties of the objectives, which accelerates and simplifies 
multi view image reconstruction (MVR) (Figure 4c).  
In conclusion, multi view imaging by sample rotation is optimal for large samples like organoids 
and model organism embryos with an extend of 200 µm and larger. Stage scan acquisition is 
highly effective for single sided, large area, thin sample acquisition, while synchronous 
piezo/slice acquisition minimizes acquired data and data processing effort for spheroid sized 
samples.  
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Figure 4 – Light sheet acquisition modes  
a) A stage rotates the sample in an FEP tube to allow for multi view acquisition. One excitation path (light blue 
arrows and single slice light sheet) combined with rotation of the sample reduce light scattering by minimizing the 
distance the light sheet needs to travel through the tissue for each view. Fluorophores are detected at a 90° angle 
(light green arrow). The final sample image is calculated by fusion of the signal from the multiple views. b) SSA 
allows to quickly image a large area, but for smaller samples like a single spheroid mounted in a Matrigel spot 
(gray), a dual view acquisition (red and green bounding box) generates a high ratio of single view, excessive data 
(yellow). Additionally, acquired stacks are skewed, which requires additional image processing steps. c) SyncA 
acquires a defined FOV with fixed parameters, but in comparison to SSA the acquired data displays a higher ratio 
of volume imaged by both views (yellow volume).  
 
1.3.6 Data generation, data handling, and multi view processing  
Light sheet microscopes are equipped with sCMOS cameras that are capable to acquire large 
quantities of data with up to 1 GB/s [113, 123]. Therefore, data management, storage, and 
processing with high performance recourses are essential for SPIM imaging [124]. Restrictive 
acquisition by focusing imaging only on the field of interest (FOI) can reduce data size, but 
intelligent solutions such as intelligent imaging and adaptive optics are shaping the current 
light sheet microscopy development [125]. The term intelligent imaging describes a partly 
automated microscope that can actively change acquisition patterns upon a specific stimulus 
and selectively store or discard data depending on its content [126]. Adaptive optics describes 
microscopes that can evaluate acquired data and actively change the detection path to 
improve image quality and focus on an automatically defined FOI [125].  
As a result of the large data sets acquired by LSFM, data science with focus on high-
throughput image processing and analysis has become an integrated part in the field of light 
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sheet imaging. Image data of multiple views need to be fused and processed [114, 127]. The 
most commonly used processing pipeline is the multi view reconstruction (MVR) plugin 
developed in the group of S. Preibisch [128]. The processing tool detects points of interest 
within all views, like fluorescent beads embedded into the mounting gel and calculates from 
these positions a transformation matrix for each view. The combined image of the specimen 
is subsequently deconvolved and can be used for further analysis. The MVR pipeline is 
especially useful for multi view imaging with two or more acquired views, needed in particular 
for reconstruction of large embryos where the embryo surpasses the FOV multiple times.  
 
1.3.7 Sample handling for light sheet based screens 
The optimal imaging capabilities of the light sheet microscope, shift the key challenges of an 
imaging screen towards sample handling and data processing. Due to the physical positioning 
of the excitation and detection objective at close proximity, commercial high-content plates 
like the 94- or 384-well plates used in 2D cell culture screen are not suited for the multi-
objective setup of some SPIM microscopes. Samples have to be positioned within a confined 
space. Recent development of single objective light sheet microscopes like the ssOPM or 
SCAPE [129, 130], enable the usage of the standard cell culture plates due to the single 
objective setup, but lack spatial resolution in comparison to the dual inverted single plane 
illumination microscope (diSPIM) system and require a positioning of the spheroid near the 
bottom of the well [129, 130]. In comparison, Strnad and colleagues developed a now 
commercially available setup, with a v-shaped FEP channel, carrying up to twenty mouse 
embryos [115]. This setup allowed for high spatial and temporal resolution, but was lacking 
sufficient throughput and suffers from elaborated sample mounting. 
In general, only one commercially available geometry represented by the ASI diSPIM system 
or the Luxendo QuVi microscope allow sufficient sample number as well as spatial and 
temporal resolution to facilitate a light sheet-based, high-content imaging screen of 3D 
spheroids. 
 
1.3.8 Dual inverted single-plane illumination microscopy 
Though originating in the field of developmental biology, novel commercial light sheet 
microscopy provides promising capabilities for many different research applications. The 
development of the diSPIM by Kumar and colleges [112] has provided for the first time a 
commercially available setup that allows to image in a horizontal cell culture setup. Although 
the nomenclature suggests otherwise, the diSPIM was conceived as upright add-on to an 
inverted confocal microscope. The dual view acquisition by two high magnification objectives 
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positioned at an angle of 90°, with a 45° angle between the objective and the stage, facilitate 
upon image processing an isotropic, high spatial resolution in samples of up to 130 µm in 
diameter for subcellular phenotypic analysis. The combination of an upright stage for 
standardized cell culture plates and the strong advantages of a LSFM system, makes the 
diSPIM system the optimal tool for a 3D high-content, live, high temporal and spatial 
resolution, quantitative screen of 3D cell culture models. 
 
1.4 Quantitative imaging screen 
In the last three decades, digital microscopy has evolved with sophisticated acquisition 
automation [126, 131], high quantum efficiency cameras [113, 132], and reproducible 
specimen labeling [100, 101]. To allow an impartial, comparative analysis of different 
specimens, a quantitative image analysis is key and the prerequisite for any imaging screen 
[133]. The comparison can be conducted between treated and untreated specimen or between 
tumor and non-tumorigenic tissue to detect communalities and differences between the 
samples. This analysis allows to characterize protein function [134], potential therapeutic drug 
targets [135], and effective drug combinations [7] as well as describe potential side effects of 
the experimental procedures.  
 
1.4.1 From a digital image to cellular phenotype description 
In a quantitative image analysis, samples are described by numerical descriptors, 
characterizing differential properties, which define the phenotype [136-138]. These can be 
features such as signal intensity, textural features, shape descriptors, quantities or differential 
values analyzed over time describing different biological processes [139]. Traditional machine 
learning methods like random forest (RF) classifier [140] or the advancing convolutional 
neuronal network classification [141-143] allow a stochastic determination of a phenotype 
class to group samples [7, 144].  
A parallelization of many functional experiments with different treatments applied, different cell 
lines, different conditions, concluded with quantitative image analysis is called a high-
throughput imaging screen. The high degree of statistical significance resulting from the high-
throughput of many samples, allows to detect strong target candidates that evoke a desired 
phenotype, but also provide means to detect subtle differences between control and treated 
sample (Figure 5) [7, 145]. Numbers of differential treatments can range from a few tens to 
hundreds of millions of different treatments, as for example applied in drug discovery in pre-
clinical trials [135]. Academic research and the private sector, for example pharmaceutical 
companies, have invested extensively in establishing small molecule inhibitor libraries to test 
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for different effects and their potential use as therapeutic [143, 146]. Other molecular tools 
such as siRNA libraries, or the discussed dCas9 fused to different effector domains and active 
CRISPR-Cas9 are nowadays also evaluated as potential methods to treat cancer cells and 
are already used to study the underlying cellular mechanisms that induce tumor initiation or 
can revert the tumorigenic, cellular phenotype [147]. 
A high degree of automation, reduced experimental volume per treatment and sophisticated 
analysis pipelines are essential to an establishment of such a high-throughput screen [148]. 
Furthermore, a high classification accuracy, rapid processing, and strong statistical 
quantification of the phenotype are essential to a resilient evaluation [149, 150].  
 
 
Figure 5 – Quantitative imaging screen of 3D cell lines for functional evaluation 
a) Cell lines are treated with different molecular perturbation methods such as drugs, siRNA, CRISPR-Cas9 or 
dCas9-effector domains (dCas9-ED) to mediate specific modifications (color-coded). b) Spheroids are imaged in a 
high-content setup with multiple samples (different treatment / different cell line / different target) being acquired at 
the same time at adequate spatial and temporal resolution to follow the process or development of interest (e.g. 
mitosis). c) High-content quantitative image analysis pipeline with phenotype classification and comparative 
evaluation allows elucidating the function of the target protein.  
 
1.4.2 Automated phenotype classification 
Different machine learning (ML) algorithms have been deployed in life science research for 
many years to process, analyze, and evaluated biological data sets. For many years, random 
forest (RF) algorithms were the state-of-the art machine learning implementation to detect 
patterns in large data sets. Image classification by RF algorithms rely on quantitative values 
describing an image such as textural features (Haralicks features), sizes, pixel intensities, 
shapes or other measurable descriptors (Figure 6a), which require a preprocessing step of 
the images to calculate these quantitative values. 
Deep neuronal networks (DNN) have gained in recent years an extensive rise in utilization in 
many everyday applications, such as voice recognition tasks or image processing [151]. A 
subgroup of DNNs is convolutional neuronal networks (CNN) which provide the basis for fast 
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and accurate image processing. In comparison, CNNs do not require extensive preprocessing 
of the images as compared to other ML classification algorithms as they analyze the entirety 
of the visual feature space (Figure 6b). These visual features can be for example the eyes, 
mouth and nose in face recognition software or in a biological related matter the state of the 
chromosomes throughout the cell cycle.  
For research applications, the capability of CNN to process, segment, and classify large image 
data sets [150] at exceeding speeds displays highly promising capabilities [151, 152], 
especially in high-throughput imaging screens [149]. 
Inspired by stimuli processing of neurons in the brain [153], CNNs are complex mathematical 
models of many interconnected nodes, so called neurons ordered in layers (Figure 6b). Each 
neuron receives multiple excitation inputs from the previous layer, called activations. 
Activations are processed in the neuron through the weights and biases (Figure 6b). When 
the sum of all activations reaches a threshold, the neuron emits an activation signal to the next 
layer. The sum of all neurons, layers and their interconnections define the properties of the 
network and how an input is processed [154]. Weights and biases and therefore the properties 
of each neuron are adjusted by the training of the CNN by a large, labeled data set. Functions 
such as gradient descent or back propagation make iterative adjustments to the weights and 
biases to optimize a model. Underlying patterns of the input image, called features, are 
detected and define the output class of the input file. 
Due to different intermediate calculations steps, of pooling multiple neuron layers and 
therefore subsampling the data, CNNs are highly robust and display low signal to noise 
interference [155]. Additional data argumentation of the training data by rescaling, rotation, 
introduction of random noise and signal variance enlarges the training data set [141]. This 
counteracts the problem of over fitting the CNN to the training data [156]. 
For classification of a small image in a DNN, already many computational matrix convolution 
calculations are needed [137, 154]. Therefore, CNNs require extensive computational 
performance power. Only in the last years, high performance graphic processing units (GPUs) 
have obtained sufficient calculation performance to do these calculation steps in parallel in a 
reasonable time frame, making DNN applicable to high-throughput image analysis steps in a 
high-content imaging screen for image classification [157, 158].  
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Figure 6 – Automated classification of mitotic phases by random forest or CNN 
a) Today two main methods allow for automated image classification by analysis of quantitative features (f1 – f13) 
or by analysis of the image. Both require labeled training data to define the classes. b) Random forest consist of 
an ensemble of decision trees. These trees utilize defined quantitative properties of a nucleus such as textural 
features (Haralicks features), shapes, sizes, pixel intensities and others to define the image class. Appropriate 
feature selection for classification and training defines the analysis process. b) In comparison, CNN imports and 
processes full images and calculates the class from pixel values. Class defining features are self-taught during 
network training through weights and biases modulation. The CNN can be seen as a black box as the entirety of 
the network, the interconnected neurons (mathematical calculations) cannot be comprehended and requiring 
extensive computational performance.  
 
1.4.3 Challenges of light sheet microscopy in high-content imaging screens  
For years, the state-of-the art microscopy system to acquire large biological data sets at high 
repetition for screening purposes was the spinning-disk confocal microscope [159]. These 
systems are highly adapted for long-term imaging, high image quality, and culture stability as 
well as equipped with sophisticated adaptive optics-modules [126, 160]. As the field of light 
sheet microscopes develops, no or only early beta adaptations of adaptive optics technologies 
ensuring long-term image quality are available for light sheet microscopes [117, 125, 161] and 
require adjustment to the specific demands of the microscopy system. Furthermore, most of 
the light sheet microscope systems in research were custom made and tailored to a specific 
usage, making a general usage of light sheet microscopes challenging for high-content 
imaging.   
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2 Aim of study 
Cell culture models and functional evaluation upon perturbation are fundamental tools to 
decipher gene function, cell function, development progresses, and tissue characteristics. 3D 
cell lines allow due to the established microenvironment a much more detailed analysis, 
resembling the in vivo physiology.  
In this project, we wanted to establish a high-content imaging screen, with a high degree of 
process automation from cell culture treatment to the final analysis of the effect of the 
treatment. Through the usage of 3D cell culture models and fast, high-content, live light sheet 
microscopy as a screening method, we wanted to optimize treatment induced phenotype 
evaluation and reduce imaging induced phototoxic effects. Additionally, we wanted to harness 
the rapid imaging capabilities of light sheet microscopes to achieve unmatched sample 
numbers.  
The workflow was intended to be applicable both in basic and medical oncology research. To 
display the capabilities in tumor research, we intended to apply the screen to study tumor 
initiation factors and induce by different means of gene regulation an abnormal, tumorigenic 
phenotype in a benign tumorigenic breast epithelia cell line. With the focus on mitotic gene 
knock-down, we aimed to induce abnormal cell divisions, incomplete genome separation, 
chromosomal instability or misdistribution of chromosomes into the daughter cells, which are 
strong hallmarks of cancer. We aimed to detect these phenotypes by high-throughput image 
analysis employing cutting edge deep neuronal network classification for high-throughput 
performance and exceeding classification accuracy. Additionally, we wanted to evaluate 
established and novel methods of gene regulation, such as the CRISPRi gene knock-down or 
dCas9-ED mediated gene regulation, and compare the cellular phenotypic effects of the 
different molecular gene regulation methods. 
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3 Results 
The project was developed and conducted in two major discrete parts that together constitute 
a workflow for high-content perturbation analysis in 3D spheroids. First, we established a high-
content imaging screen utilizing advanced light sheet 3D microscopy to acquire images of 
spheroids at high temporal and spatial resolution. In the second part, we applied this workflow 
to MCF10A and HEK293 3D spheroids and analyzed the effects of epigenomic or 
transcriptomic modifications on global and cellular phenotype. The quantitative image analysis 
of the induced cellular and spheroid characteristics allowed an evaluation of target gene 
function in spheroid development and clonal growth as well as epigenetic regulatory 
mechanisms. 
 
3.1 3D cell culture imaging by diSPIM  
3.1.1 Comparison of light sheet and spinning disc microscopy  
With the development of the commercial dual inverted single plane illumination light sheet 
microscope licensed by Applied Scientific Instrumentation (ASI), the advantages of light sheet 
microscopy were for the first time available for high-content imaging of 3D cell cultures in 
standardized cell culture environments. 
To evaluate the imaging parameters and improve image quality in comparison to high-content 
screen (HCS) microscopy systems, we acquired images of six day old MCF10A H2B-GFP 
spheroids with a diameter of about 80 µm with a spinning disc microscope and the diSPIM 
light sheet system. The stable labeling of histone subunit 2B in the MCF10A cell line with a 
GFP fluorophore enabled us to track the DNA throughout the cell cycle as well as image 
nuclear morphology. 
Following the suggestion by Cole and colleagues [162], we decided to acquire with the diSPIM 
at a three-fold Abbe resolution limit oversampling in all axes, which would optimize image 
quality, but also increase data size, single file acquisition time, and light exposure. In total, a 
single position, single time point, dual view (90° rotated view) acquisition with a single channel 
(excitation wavelength), from now on termed “position scan”, comprised 520 slices (260 slices 
per view) each slice with 1024 x 1024 pixels and a resolution of 0.1625 pixel / µm, resulting in 
a position scan data size of 1.1 gigabyte (GB). When the two orthogonal views per position 
scan were aligned, a total volume of 130 µm x 130 µm x 162.5 µm could be acquired from 
both views. 
For comparability, the SDM system was set to acquire at the same spatial XYZ resolution and 
maximal signal intensity. We optimized the excitation path settings of the diSPIM to form a 
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Gaussian beam with a threefold larger YZ-diameter at the FOV border, in relation to the YZ 
extend at the image center giving us the highest optical sectioning at the X-axis center. 
In comparison to the current spinning disk microscope system used for live, high-content, 3D 
imaging screens, the diSPIM setup outperforms the conventional SDM setup in almost every 
acquisition parameter such as laser power density, acquisition duration and signal-to-noise 
ratio (Table 1), though acquiring at a higher spatial resolution and shorter exposure time. 
The biggest advantage of the light sheet microscope over the SDM became apparent when 
the region of interest is located deeper inside the tissue or spheroid (Figure 7). Due to signal 
scattering as the photons travel through the tissue, we were not able to acquire the strong 
signal of the MCF10A H2B-GFP nuclei deeper than 80 µm inside the sample with the SDM. 
In comparison, using the same specimen, we were able to image throughout the entire 
spheroid with the diSPIM system. By applying image processing and combining visual 
information from both optical paths, we were able to achieve exceptional isotropic image 
quality, essential for quantitative image analysis of the entire spheroid (Figure 7). 
 
Table 1 – Comparison of spinning disc and diSPIM imaging parameter 
Quantitative comparison of acquisition properties and resulting image quality between spinning disc microscopy 
and diSPIM systems. Acquisition parameters were set to generate Z-stacks with close to identical Z-stack 
acquisition properties. Imaging parameters listed describe acquisition parameter, light input (measured at the 
sample) and acquired image properties.  
	 spinning	disc	microscope	 diSPIM		
XYZ	stack	(px	x	px	x	n_slices)	 1004	x	1002	x	233	 dual	(1024	x	1024	x	260)	
XY	pixel	resolution	 0.2	µm	/	px	 0.1625	µm	/	px	
measured	laser	power	 1,320	µW	/	s	 320	µW	/	s	
exposure	/	slice	 50	ms	 1.75	ms	
stack	acquisition	duration	 53.2	s	 4.5	s	(+	15	s	processing)	
signal-to-noise	ratio	 43.25	 127	
avg.	background	signal	 18.4	 0.941	
power	density	/	phototoxicity	 168,000	W/cm2	 40,700	W/cm2	
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Figure 7 – Comparison of spinning disc and light sheet imaging of 3D spheroids 
Direct comparison of spinning disc and light sheet imaging performance of MCF10A histone 2B – GFP spheroids 
acquired six days after seeding of single cells in Matrigel with a size of about 80 µm in diameter. XY and XZ 
maximum projection of full 3D stack (scale bar = 50 µm) represent the XYZ acquisition capabilities of SDM and the 
diSPIM. Inserts represent single nuclei close to the detection objective (green box) or imaged 80 µm inside the 
sample (red box) (scale bar (insert) = 10 µm), with insert Z-stack slice depicted by red and green line.  
 
3.1.2 MCF10A – a valuable model for siRNA knock-down studies 
For this project, we decided to use mainly the MCF10A benign cell line as a model to establish 
the high-content perturbation analysis workflow utilizing light sheet microscopy technology for 
phenotype evaluation. Single MCF10A cells grow clonally under 3D culture conditions to 
multicellular spheroids, following a defined developmental trajectory (Figure 8a), which 
allowed us to study the function of single genes in development and cellular growth by siRNA-
mediated knock-down.  
We used an MCF10A cell line endogenously expressing H2B-GFP proteins that label the DNA 
[163]. This cell line allowed us to follow and describe in detail single nuclei and DNA properties 
throughout the different stages of the cell cycle, as well as analyze the development of the full 
spheroid (Figure 8b). Furthermore, the MCF10A cell line is highly susceptible to the 
transfection of siRNA and therefore allowed an effective influence on cellular homeostasis. 
Initial experiments showed that siRNA solid phase reverse transfection of PLK1 targeting 
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siRNA evoked in 94% of all MCF10A cells a metaphase cell cycle arrest, while only 43 % of 
HEK293 cells displayed this phenotype (Figure 21a). PLK1 is a serine/threonine-protein 
kinase essential for the centrosome maturation and spindle assembly as well as the removal 
of cohesins from chromosome arms. A knock-down of PLK1is known to arrest the cell cycle 
in prometaphase.  
The high transfection efficiency of siRNA into MCF10A cells allowed us to use this benign cell 
culture model in a HCS as only few cells would not be transfected. Therefore this approach 
provided us with a highly reliable readout of the knock-down phenotype. For the low 
transfection efficiency of HEK293 cell lines, many analyzed spheroids would have been 
untransfected and therefore alter the phenotype quantification by showing wildtype properties.  
 
3.1.3 Long-term imaging of 3D spheroids by dual inverted light sheet microscopy 
With the established imaging setup and acquisition parameters, we achieved high image 
quality of our 3D cell culture model (Figure 7), while administrating a low light dose onto the 
spheroids (Table 1). The non-invasiveness of the imaging can best be described by the fitness 
and viability of the imaged MCF10A spheroids throughout high repetition, long-term imaging 
(Figure 8a).  
We were able to image a wild type MCF10A H2B-GFP spheroid, stained with a tubulin live 
dye (SiR-Tubulin) in dual color throughout the entire development from the two-cell stage (five 
hours post seeding) to a full-sized spheroid at an interval of ten minutes for up to six and a 
half days (155.6 hours) (Figure 8a). We could detect cell divisions and cell motility throughout 
the entire time lapse. With the ten-minute time interval, all stages of the mitosis are visible 
(Figure 8b). 
Throughout the acquisition, we only needed to do minor position adjustments to some of the 
acquired spheroids after two days of constant imaging, highlighting the high position stability 
of the microscope, while traveling large distances between different positions. Spheroid 
movement was mostly caused through shrinkage of the Matrigel with an average displacement 
of 13.97 µm in X, Y and Z over 24 hours of imaging at a position approximately 200 µm above 
the plate (Supplementary Figure 1).  
For the purpose of phenotype evaluation upon target gene knock down, we were not able to 
image the full development of six days of each spheroid due to data size constrains. We 
therefore selected day five to six for the 3D high-content screening approach. Spheroid 
“imaged” at a five-minute interval for 24 hours (avg. 62.25 nuclei count) during this defined 
time frame, show the same increase in nuclei total number as “non-imaged” spheroids (avg. 
57.7 nuclei count), analyzed by start- and end-point evaluation (Figure 8c)  
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Figure 8 – Long-term imaging capabilities of the diSPIM 
a) Example untreated MCF10A H2B-GFP spheroid imaged over 156 hours / 936 time points (t) every 10 minutes 
from the two-cell stadium to the fully developed spheroid in dual channel (H2B-GFP / SiR-Tubulin dye) (scale 
bar = 50 µm). b) High temporal and spatial resolution enable a detection of the different cell cycle stages (pro-, 
meta-, anaphase), while distinct features of the cytoskeleton could be detected (scale bar = 25 µm). c) Nuclei count 
mean fold enrichment of imaged and non-imaged spheroids in 24-hour acquisition cycle representing the 
developmental stage of the spheroids during the HCS acquisition time frame of MCF10A spheroid development 
(nimaged = 31 / nnon-imaged = 33, error bars represent standard deviation). 
 
3.2 High-content light sheet imaging screen  
In this project, we aimed to utilize the capabilities of the light sheet microscope to analyze and 
compare multiple different treatments that influence the cellular phenotype associated with 
tumor development. 
 
3.2.1 Target selection  
As imaging screens rely on visual features, we decided to focus on perturbing the cell cycle, 
since alteration in this key cellular process can be visualized by DNA labeling and as described 
in 1.1.4 are a regular cause for cancer initiation.  
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For phenotype validation and comparative analysis, we used different methylome-
modifyingifying effector domains fused to deactivated CRISPR-Cas9 (dCas9-ED) for 
epigenome modulation. In comparison to RNAi, the dCas9-ED relies on a protein component 
(Cas9 fused to a methylome-modifyingifying effector domain) and an RNA component (single 
guide RNA) that need to be introduced into a single cell to induce epigenome alterations 
(1.2.2). Both of these methods can be applied to induce a specific transcriptome alteration, 
targeting only single genes, which allowed us to compare these methods by the phenotype.  
 
 
Figure 9 – Target gene selection 
Target genes for the screen were selected by their role in cell cycle progression, as described by multiple online 
gene data bases (1. genecards.org / 2. mitocheck.org / 3. mitosys.org / 4. cyclebase.org / 5. uniprot.org) and a 
strong correlation of CpG-me level and gene misregulation. This allows a comparison of the knock-down phenotype 
induced at translational level in comparison to the knock-down induced at the transcriptomic level. Regulatory CpGs 
can be correlated (low CpG-me level = reduced gene expression (magenta)) or anti-correlated (high CpG-me 
level = reduced gene expression (cyan)) with expression of the target gene. Single target genes, could display both 
types of CpG-me relations - correlated and anti-correlated regulatory CpGs such as found in AURKA, CEP85, 
MEIS2 and RGMA (white area). Example of correlated and anti-correlated CpG displayed for CDC6 (one of two 
anti-correlated CpGs), RGMA (one of four anti-correlated CpGs and one of three correlated CpGs) and CDCA5 
(one of seven correlated CpGs). Tumor samples are depicted by a blue dot, while control (non-tumorigenic) tissue 
measurement is marked by a red dot. 
 
Due to the fact that siRNAs can be designed specifically for any target gene as well as the 
sgRNA for a site-specific dCas9 targeting of the methylome-modifying effector domain, it was 
essential to select for target genes involved in mitosis with distinct knock-down phenotypes 
and most importantly show a strong correlation of gene expression an alter methylation level 
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at defined regulatory, genomic regions. With the modulation of the methylome at these 
regulatory sites, we expect to induce in comparison to the siRNA regulating at translational 
level, a knock down through the modulation at the transcriptomic level (1.2.1). 
In collaboration with Dr. Carl Herrmann, we bioinformatically selected 28 target genes that 
matched these criteria. These target genes displayed either in the promoter region or a distal 
regulatory region one or multiple CpGs that displayed a high correlation (> 0.5) or anti-
correlation (< -0.5) between CpG methylation level and gene expression (Supplementary 
Tables 1 / Figure 9). The correlation was detected by comparison of tumor- and non-
tumorigenic patient tissue CpG methylation level and gene expression data from a 450k 
Illumina breast cancer patient screening data set [164] available on UCSC genome browser 
[165]. 
 
3.2.2 High-content 3D light sheet screen workflow 
The fundamental aim of this work was the establishment and biological evaluation of a high-
content live imaging screen that can be used in 3D cell culture and efficient perturbation 
assays and tumorigenesis studies. Therefore, we optimized the workflow comprising all steps 
of a HCS from sample preparation, to high-content imaging, to image analysis described in 
detail in Figure 10.  
To conduct an imaging screen using the diSPIM system, we planned to evaluate the 
phenotype of many different modified samples simultaneously, with each spheroid sample 
grown from a single treated cell. The manual preparation of each sample by hand would have 
required an intensive manual effort and led to small individual differences in transfection mix, 
spot size, cell seeding density and preparation duration, which in combination would have 
corrupted the outcome of the screen.  
Due to these reasons, we established a solid-phase reverse transfection mix procedure, 
optimized for maximal siRNA and plasmid transfection efficiency (Figure 21a) of the different 
cell lines (Figure 10): Following transfection in 2D in a 96-well format, we mixed the cells with 
Matrigel and spotted the cell-Matrigel mix of all samples simultaneously with a liquid handling 
robot. The usage of a robot further reduced manual labor, reduced spot volume to a minimum 
of 0.2 µl, and positioned samples precisely in a defined pattern. 
 Furthermore, the usage of the Hamilton liquid handling robot for sample spotting facilitated 
defined pre-screen spheroid position detection as well as reduced the duration of the sample 
mounting in the imaging dish to 30 minutes. Subsequently, spotted samples were relocated to 
the incubator for spheroid development. Five days into 3D spheroid development under 
standard culture conditions, we detected in a low-resolution diSPIM pre-screen each 
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spheroid’s position within each of the 320 Matrigel spots as well as general properties such 
as spheroid size and circularity. These features allowed us to automatically select the maximal 
number of 38 spheroids to be imaged at five minutes interval for the subsequent HCS by the 
optimal imaging position at the apex of the matrigel spot, while eluding 2D cell layers.  
Additionally, we defined manually two dual view stack positions of beads immersed in Matrigel 
essential for point spread function (PSF) detection and dual view registration, giving a total of 
40 positions acquired per HCS at a five-minute interval reaching close to the maximum 
imaging performance of the diSPIM system. 
 
3.2.3 3D spheroid diSPIM imaging screen of siRNA mediated knock down phenotypes 
In total, we used for each of the 28 target gene two distinct siRNAs (siRNA set 1 and set 2) in 
three replicates, giving us a total of six perturbation samples per target gene. These six 
spheroids were subsequently imaged by high-content light sheet imaging. Together with the 
positive and negative transfection control we acquired a total of 228 spheroids in six individual 
experiments.  
 
3.2.4 Image processing pipeline 
The data size produced per HCS of ~10 terabyte (TB) (total of 60 TB in six experiments) raw 
data challenges standard IT infrastructures with regard to storage capacity and data 
processing. Therefore, we developed a data processing tool called “hSPIM”, which ran directly 
on the workstation controlling the diSPIM system (Figure 10, Figure 11a). This tool avoided 
the need for a large data set transfer infrastructure or high performance cluster calculations. 
HSPIM combines the signal information of the two diSPIM views to calculate an estimate of 
the most probable image, given the point spread function provided by the bead reference 
image. As signal quality degrades deeper in the sample tissue due to light scattering (1.3.2), 
the second view was essential to the screen to compensate for signal loss in the large 
spheroids and to provide isotropic resolution to display the spheroid samples.  
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Figure 10 – siRNA konock-down high-content light sheet screen 
There are three key steps of the high-throughout light sheet imaging screen: 
Step 1 – sample preparation: solid-phase reverse transfection of cell line in 2D in a 96-well format with two different 
siRNAs (siRNA set 1 and siRNA set 2) per target gene transfected separately. A total of three complete HCS were 
conducted, resulting in six acquired samples per target gene. Treated cells were subsequently mixed with Matrigel 
and spotted onto a one-well imaging plate. Over five days spotted cells clonally expand into 3D spheroids growing 
in the Matrigel spots. 
Step 2 – diSPIM imaging: In a low-resolution stage scan pre-screen, positions of all spheroids were detected. 
Samples for imaging were selected by position in Matrigel spots, while unsuited spheroid clusters of two or more 
fused spheroids as well as 2D cell layers were excluded. Subsequently, 38 individually treated samples were 
imaged for 24 hours every 5 minutes by dual view light sheet imaging acquiring two full stacks of view A (red) and 
view B (green) at a 90° angle. 
Step 3 – data processing: Raw data was processed by image deconvolution and fusing visual information of view 
A and B together. Additionally, the image bit depth was reduced to 8-bit. This processed data was subsequently 
used to analyze the phenotype of each spheroid throughout the entire screen in regard to global spheroid properties 
as well as single segment (single nuclei) features and development.  
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With the available hardware and most calculations executed in parallel on a high-performance 
GPU, we were able to process the raw data of one position stack file within 8.23 seconds 
which reduced the data size from 1.1 GB to 80.1 megabyte (MB) per position scan with 
significantly improved XYZ isotropic resolution and signal-to-noise ratio (Figure 11a). Because 
the background signal from the surrounding Matrigel could be deducted and foreground signal 
of the nuclei were automatically detected, a reduction from a 16-bit to 8-bit TIF file format did 
not result in significant information loss, as well as a two by two-pixel binning, enabling the 
strong decrease of total data size from 1 GB to 80 MB per single time point position stack. 
The hSPIM tool is in its principle based on the multi-view deconvolution developed by Stephan 
Preibisch and colleagues [128, 166]. Novel in our SPIM image processing approach was the 
separation of beads and sample, meaning that the registration matrix and PSF were detected 
in a dedicated spot of beads mixed in Matrigel (Figure 11a). PSF and registration were 
subsequently applied to all other processing calculations of sample images.  
Even for large distances between individual samples of up to 10 centimeters, the transfer of 
the registration matrix and PSF was highly successful. When we applied the PSF and 
registration of bead position 0 (Pos0) onto a secondary bead position 39 (Pos39) at the end 
of a multi position scan cycle with long traveling ranges of the stage, we found a displacement 
between the two registration matrixes of less than 162 nm (Supplementary Figure 2). The 
transfer of registration matrix and PSF from one position onto others thus produces accurately 
registrated and deconvolved images throughout a full screen in time and space. Thus, the 
approach of separating bead and spheroid positions reduced the background signal in the 
images, avoided the need to subtract the beads from the output image and reduced the 
necessary steps to a single calibration calculation per time point, while retaining optimal quality 
for all other sample images (Figure 11a). 
The hSPIM pipeline provided additionally to the fusion image the possibility to segment nuclei 
and calculate texture features for each nuclear segment, which subsequently can be used for 
segment classification and a quantitative analysis.  
Computation duration in the given hardware framework (6.3.1.1) took 35.6 seconds per time 
point to detect PSF and registration matrix, while image fusion and deconvolution required 
4.8 seconds and the segmentation and feature extraction an additional thirteen seconds of 
computation per position scan. Due to the parallel processing capabilities of the modern GPUs 
with five files being processed in parallel the total duration for the hSPIM pipeline was on 
average eleven hours and fifteen minutes.  
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Figure 11 – diSPIM data processing and analysis 
Raw diSPIM imaging data with 1 GB data size was processed and analyzed quantitatively. a) hSPIM is a 
processing pipeline developed specifically to diSPIM acquisition parameters and data structure. In a calibration 
step, the registration matrix and the PSF are detected in the dedicated bead position. These are subsequently 
applied to process all sample positions by Richardson-Lucy multiview deconvolution. From each processed image, 
nuclei are detected, segmented, and for each segment textural features (Haralicks features) are calculated. The 
processed image (fusion), the features and the label image are stored as output reducing the data to 80 MB per 
spheroid and time point. b) KNIME processing pipeline for high-content quantitative analysis uses the hSPIM output 
data to analyze cellular and global features of the spheroid to evaluate and compare the phenotype of all samples 
resulting in a quantitative description of different global spheroid and single nuclei features stored in a 480 KB sized 
CSV file (scale bar = 50 µm). 
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The output of the hSPIM software package was subsequently imported to a pipeline 
implemented in the Konstanz Information Miner (KNIME) software [167] to compute key 
quantitative properties of the development of the spheroid and each single nucleus 
(Supplementary Tables 2). Together, these properties described in detail the individual 
spheroid’s phenotype and put cellular and subcellular processes into the context of the 
development of the entire spheroid. Differential phenotype analysis of non-targeted control 
siRNA and target gene knock-down spheroids allowed a functional evaluation of each gene of 
interest.  
 
3.2.5 Cell cycle stage classification with a deep neuronal network 
The key feature of the KNIME image analysis pipeline was the detection of the prominent four 
cell cycle stages (inter-, pro-, meta- and anaphase) of every single nucleus. To define the cell 
cycle stage of each nucleus throughout the entire screen, we tested two different means of 
automated image classification: a random forest classifier and deep learning image 
classification using a convolutional neuronal network (Figure 12).  
For RF nuclei classification, we used the thirteen textural Haralick features calculated by the 
hSPIM light sheet data processing software (Figure 12a). Our RF model was trained with these 
features taken from 1,643 manually classified nuclei. With this training set and our 
computational hardware, we achieved a classification accuracy of 83.1% and 4.25 seconds 
computation time per nucleus (Figure 12c).  
In comparison, DL classification performed much faster with only 3.7 ms classification 
calculation time per image with the applied VGG-based convolutional neuronal network [154] 
(Supplementary Figure 3). However, using the maximum intensity projection image of the 
same 1,643 nuclei as for our RF model training as input for the DNN training resulted here in 
a considerably lower prediction accuracy of only 74.75% as compared to the RF classification 
(Supplementary Figure 4). Nonetheless, the accuracy could be dramatically increased by 
increasing the training data set and most notably through the implementation of the “3D-2D 
plane classification” (Figure 12c). In developed 3D-2D plane classification, we preprocessed 
each 3D nucleus stack individually and used the 2D slices of the XY, XZ, and YZ orientation 
for training and later for segment classification (Figure 12a). This preprocessing increased the 
number of images representing each nucleus from a single maximum projection to about 60 
images in three orthogonal view angles.  
Predominantly, we established 3D-2D plane DL classification to avoid misclassifications 
caused by mitosis orientation or maximum projection artifacts. Cells in 3D cell culture divide 
in all 3 dimensions, unlike in 2D cell culture, where the culture dish defines the orientation of 
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division and therefore defines the visual traits of the different cell stages captured by the 
microscope. Only the inter- and prophase are in their respective 3D visual representation 
rotation invariant.  
With this 3D-2D plane classification preprocessing step implemented, we achieved a much 
higher classification accuracy of 95.8% and computation duration of only 88 ms per nucleus 
classification (Figure 12b-c).  
 
 
Figure 12 – Prediction accuracy of machine learning classifications 
a) As input we used the 13 Haralicks features (F1-13) calculated by the hSPIM diSPIM data processing pipeline 
for random forest classification and 2D images of the XY, XZ, and YZ slices of a 3D nucleus for the deep learning 
classification, respectively (scale bar = 5 µm). b) The different input formats of the same nuclei (n=1,643) manually 
classified results in 21,359 data points used for the RF classifier training, while the 3D-2D plane deep learning 
classification training was conducted with a total of 98,580 16-bit images. c) Cross correlation measurement 
describes the classification accuracy and allows an evaluation of potential misclassification. d) In direct 
comparison, classification differences between RF and 3D-2D plane DL classification can be visually detected 
(magenta arrows), when applied to the same data (scale bar = 50 µm). 
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3.2.6 Control MCF10A spheroid cell cycle under screening conditions 
The high accuracy of cell phase detection by DL classification paired with the high temporal 
resolution of the acquisition allowed us to follow a single cell through the different phases of 
the cell cycle (Figure 13a), while the high isotropic spatial resolution allowed us to calculate 
the ratio and size reliably of the different cell cycle stages (Figure 13b-c). In the control sample 
transfected with a non-targeted siRNA, 94.7% of all nuclei throughout the time lapse were 
classified as interphase, 0.9% as prophase, 1.2% as metaphase and respective 3.2% as 
anaphase (Figure 13b / Table 2). When we tracked the average duration of the different cell 
cycle phases, we detected a similar mitotic phase distribution with the prophase progressing 
for an average of 13.3 minutes, the metaphase for 11.25 minutes and the anaphase for 13.75 
minutes (Figure 13a / Table 2) resulting in an average of 38.3 minutes for a cell to transition 
through the four cell cycle stages. Due to the time resolution of five minutes’ acquisition 
intervals a more precise determination of the duration was not possible, but similar stage 
duration times with a total of ~ 50 minutes were also detected by Cai and colleagues [168] in 
HeLa Kyoto and U2OS cells. From the individual segment size, we detected that the prophase 
segments were on average the largest with 28,311 voxels, followed by inter- and metaphase 
nuclei with a size of 17,238 voxels and 16,865 voxels, respectively. Anaphase nuclei were the 
smallest on average with 9,660 voxels per segment (Figure 13c / Table 2). 
Additionally, we analyzed the linear regression of the ratio of the cell phases throughout the 
screen time lapse. On average, none of the cell phases of the control spheroids gained or lost 
significant representations with differences in ratio between start and end of the acquisition of 
less than 0.01% (Table 2). 
Furthermore, we evaluated the position of each segment in relation to the center of the 
spheroid, as it is often speculated that position within the tissue influences cell cycle 
localization [169]. In contrast, we could not find a clear predominant localization of the pro-, 
meta- and anaphase relative to the surface of the spheroid, as all classes are homogenously 
radially distributed in our MCF10A spheroids at day six of clonal development (Figure 13d). 
 
Table 2 – Control sample properties throughout 24 hours development 
developmental	feature	 interphase	 prophase	 metaphase	 anaphase	
average	class	percentage	(%)	 94.7	 0.9	 1.2	 3.2	
class	duration	(min)	 	 13.3	 11.25	 13.75	
segment	size	(voxel)	 17,238	 28,311	 16,865	 9,660	
segment	size	(ratio	to	interphase)	 1	 1.64	 0.98	 0.56	
gain	/	loss	class	percentage	(%)	 -0.0062	 -0.0027	 0.0003	 0.0038	
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Throughout the 24-hour imaging time course, control spheroids gained an average of 16.5 
additional nuclei and grew by an average of 46.4% in volume (Figure 13e-f / n = 12 control 
spheroids). 
 
 
 
Figure 13 – Image analysis of processed diSPIM data of control spheroid 
Global spheroid and single nuclei properties of the negative control samples throughout the HC diSPIM imaging 
screen. a) Example time lapse (t (time point) 175 – 187) of a cell undergoing mitosis with the main stages of the 
mitosis detected by deep learning image classification (scale bar = 5 µm) with inter- (white), pro- (green), meta- 
(yellow), anaphase (red). b) Bar plot displaying total class fraction of the different cell cycle stages throughout the 
HCS (n = 205,068). c) Bar plot showing average class segment size and standard deviation from voxel count 
(n = 205,068). d) Violin plot describing class, distance and number of segments in regard to their distance from 
center of the spheroid (n = 205,068). The black dot describes the median and the whiskers the 25%-75% 
interquantile range e) Four exemplary time points (t) of the spheroid development imaged over 24 hours (time point 
1 – 290) with the classified cells, hull and segment maximum projection displayed (scale bar = 50 µm). f) Average 
growth ratio of all control samples (non-targeted siRNA; n = 12) displayed in dot plot with the time points displayed 
in e) highlighted in red.  
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When we analyzed all cell cycle transitions of each of the nuclei in the control samples, where 
we expect a biological cell to transition throughout the cell cycle from interphase to prophase 
to metaphase to anaphase, we detected a ratio of 99% cell cycle transitions that are following 
this normal transition pattern (normal = 146,101 / abnormal: 1,380 cell cycle transitions), again 
displaying the high classification accuracy of the deep learning (Figure 12) classifier 
exemplified in a mitotic cell in Figure 13a and the low effect on the cellular viability during light 
sheet imaging. We observed that single dying cells display a high degree of abnormal 
transition patters as the apoptotic condensed DNA (ACD) is regularly classified as pro- or 
anaphase (Supplementary Figure 5).  
 
3.3 Detection of aberrant mitotic phenotype by automated visual feature 
evaluation 
3.3.1 Screening for siRNA-mediated phenotype induction 
In total, we acquired 3D time laps images of six spheroids per target gene (Supplementary 
Tables 1) of each of the 28 selected target genes. To detect abnormal mitotic phenotypes 
upon gene knock-down in each of the spheroids, we used the different visual features 
(Supplementary Tables 2 / Table 2) to characterize the individual spheroid phenotype. We 
evaluated each spheroid independently and combined all 23 features to rank and group 
phenotypes (Figure 19e-g). We used INCENP as positive transfection control as the siRNA-
mediated knock-down of this gene results in a severe macronuclei phenotype that can be 
easily detected and distinguished (Figure 15b). Non-coding siRNA was used as negative 
control.  
 
3.3.2 Aberrant mitosis duration 
Cell cycle arrest or an elongated mitosis are severe phenotypes describing strong 
perturbations in cell growth and development. To detect an abnormal mitosis duration or a 
prevalent cell phase, describing a possible cell cycle arrest, we analyzed the relation of the 
different cell phases for each sample on average throughout the entire time lapse (Figure 14). 
The non-coding siRNA transfected negative control displayed on average 5.3% of all cells at 
a mitotic class of the cell cycle (Figure 14a). The INCENP positive control on the other hand 
displayed a strong increase of the prophase class to 46%, while the number of nuclei in 
interphase decreases to 44% (Figure 14a). Other gene knock-downs such as PRC1 and 
RGMA also induced an increase in the prophase class, although less pronounced than 
INCENP knock-down (Figure 14b). PLK1 and ESYT2 knock-down spheroids displayed an 
increase in all mitotic classes, indicating an elongated mitosis (Figure 14c). MYC and ATOH8 
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knock-down display an increase in anaphase classed segments, possibly describing an 
increase in apoptosis (Supplementary Figure 5) or cell cycle arrest during chromosome 
segregation (Figure 14d). An overview of all cell cycle class ratios can be found in 
Supplementary Figure 6.  
 
 
Figure 14 – Detection of abnormal mitosis duration induced by different siRNAs 
Bar plot describing the total nuclei count as fraction of the different cell cycle classes. a) Negative control samples, 
transfected with non-coding siRNA (NC) and positive transfection control spheroids (INCENP) display distinct 
mitotic class distributions. b) PRC1 and RGMA showed an increase in prophase, c) PLK1 and ESYT2 show an 
overall increase of all mitotic phases, d) while MYC and ATOH8 displayed an increase of the anaphase class.  
 
3.3.3 Abnormal positioning of cell cycle phases 
Next, we evaluated the localization of the different mitotic phases within the spheroid under 
perturbation conditions. We used the distance to spheroid center measurement and displayed 
these in a violin plot (Figure 15). This analysis method allowed us to evaluate a possible biased 
localization of any class to the surface or inside of the spheroid. Additionally, this analysis 
technique provided us with the possibility to visualize size difference between the control 
siRNA and the target gene knock-down phenotype across each of the different samples.  
The non-coding siRNA transfected spheroid had a mean distance of all segments of 95.8 pixel 
or 31.1 µm from the center of mass. None of the four cell phase classes had a preferred 
localization to the outside or inside of the spheroid (Figure 15a) which would describe an active 
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movement of the nuclei for the purpose of cell division induction, as known in neuronal 
progenitor cells [170]. Additionally, the density plot displays a homogenous distribution within 
the 25%-75% interpercentile range, describing a homogeneous phenotype throughout all six 
replicates.  
The knock-down of INCENP in the positive control sample on the other hand induced reduced 
spheroid growth indicated by a decrease in the median with an average of ~26 px or 8.5 µm 
distance for all nuclei from the center of the spheroid (Figure 15b). Other samples, like DSE 
knock-down spheroids displayed also a reduced growth throughout all imaged samples and 
cell cycle stages (Figure 15c), depicted by the unimodal violin plot, with an average distance 
of ~48 px or 15.6 µm. 
 
Figure 15 – Class positioning describes phenotypes across multiple siRNA knock-down samples 
The class distribution displayed as violin plots of different selected samples with distinct abnormal properties 
appended by two representative images of maximum and minimum sized spheroids of the respective sample at 
the start of the time laps acquisition. a) Negative control (non-targeted siRNA) and b) positive control siRNA 
(INCENP) spheroids. Additional example specimens with abnormal class distribution are displayed for c) DSE, d) 
RGMA, e) AURKA f) PLK1 (scale bar = 50 µm). The black dot describes the median and the whiskers the 25%-
75% interpercentile range. 
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The violin plot of PLK1, RGMA, and AURKA knock-down samples displayed multimodal 
distance-to-center distributions (Figure 15d-f). This distinct distribution described a reduced 
growth of single spheroids, while others develop similar to the negative control without any 
constraints in growth which could represent untransfected cells. A summary of all violin plots 
for each knock-down sample can be found in Supplementary Figure 7.  
 
3.3.4 Cell cycle transitions  
Due to the high temporal resolution of the acquisition, we were able to track single cell 
throughout the time laps and its individual cell cycle. This allowed us to determine whether a 
cell underwent in normal sequence the key phases of the cell cycle with the succession of 
interphase followed by prophase, followed by metaphase, followed by anaphase and back to 
interphase. This biologically “normal” progression can describe a healthy spheroid and no 
“abnormal” cell cycle progression would be expected. The 95% accuracy of the cell cycle 
classification (Figure 12) provided the essential prerequisite for this analysis.  
High amounts of misclassification can occur due to abnormal nuclear shapes or textural 
features as found in abnormal nuclear phenotypes. Macronuclei are often misclassified as 
prophases or apoptotic cells or apoptotic condensed DNA phenotype can be misclassified as 
prophase or anaphase (Supplementary Figure 5). These misclassifications were detected as 
abnormal cell cycle progression. In these cases, a prophase was regularly followed by 
anaphase (ACD phenotype) or a cell transitioned back and forth between a pro- and 
interphase (macronuclei phenotype). The ratio of normal cell cycle progression to an abnormal 
cell cycle progression allowed us to evaluate viability of the sample upon target gene knock-
down and detect cells with abnormal visual features or apoptotic cells (Figure 16). 
In this analysis, beside the positive control of INCENP knock-down (p-value ≤0.001) with the 
described macronuclei phenotype, PLK1 (p-value ≤0.01), EME1 and CEP85 (p-value ≤ 0.05), 
displayed a high degree of false transitions due to cell cycle arrest and apoptosis. Conclusive 
count of normal and abnormal cell cycle transitions for all target genes can be found in 
Supplementary Tables 3. 
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Figure 16 – Normal versus abnormal transitions describe sample viability 
Box blot displaying the ratio of normal and total number of cell transitions of each of the target gene knock-down 
samples with the 95-confidence interval displayed as box, as well as the mean of all samples. Magenta line 
represents average ratio of the negative control sample (NC). t-test describing statistical significance with a p-value 
below 0.05 between the individual sample and the negative control are marked (p-values: *** ≤ 0.001, ** ≤0.01, * ≤0.05). 
 
3.3.5 Cell cycle class size 
As cells transition through the different stages of the mitosis, we detected a change in the 
segment size of the different mitotic stages described in Figure 13. We also compared on 
average the size in voxel of the different segment classes individually and clustered them by 
their size. This analysis allowed us to describe in comparison to the negative control sample, 
the cellular properties of the knock-down phenotype and detect outliers such as the positive 
control INCENP (cluster V - Figure 17) and BUD31 (cluster IV - Figure 17), which have such 
a distinct difference in size of the inter- and prophase that these phenotypes define a cluster 
each on their own. Increased prophase (cluster III - Figure 17) and respective increased 
interphase (cluster II - Figure 17) nuclei define the other clusters describing individual effects 
on the cell upon target gene knock-down.  
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Figure 17 – Nuclei size throughout the cell cycle 
Ranked based knock-down target gene clustering (cluster I-V) of the different target knock-down samples by the 
average nuclei size in voxel (color gradient) of the different mitotic classes (meta-, ana-, inter-, prophase).  
 
3.3.6 Global spheroid structure evaluation 
In addition to the analysis of single cells and their individual properties, we also analyzed the 
global spheroid appearance and its development over time. A combination of spheroid 
properties such as nuclei count, spheroid volume and the gain in volume as well as spheroid 
roundness allowed a further evaluation and comparison of the phenotypes induced upon 
target gene knock-down. A ranked based clustering of these properties facilitated furthermore 
the detection of samples with similar properties such as spheroid growth, nuclei density, 
abnormal spheroid shape and volume increase (Figure 18). Non-coding siRNA transfected 
negative control spheroids as well as all samples of cluster A displayed in comparison to 
severe knock-down phenotypes of the positive control (INCEMP) a strong growth in segment 
(nuclei) count, while retaining a roundish shape throughout the screen that resembles closely 
a sphere. In comparison, reduced growth and an abnormal shape was detected in samples of 
cluster E (Figure 18) such as CEP85 for example.  
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Figure 18 – Global spheroid properties 
Global spheroid properties such as total nuclei count, spheroid volume at the acquisition start, spheroid growth 
throughout the screen and spheroid shape describe on average the global phenotypes of each target gene. By 
ranked based gene clustering (cluster A – E) of these properties, we achieved a clustering of similar phenotypes. 
Example images for cluster A, C and E display a non-coding negative control, LHFP and CEP85 siRNA transfected 
spheroid, the hull describing the spheroid volume and the individual segments maximum projected onto a single 
plane (scale bar = 50 µm). 
 
3.3.7 Completing the picture – ranked based clustered phenotype analysis 
To complete the picture of the individual effect of the gene knock-down onto spheroid 
development and the individual cell, we compared all 23 features (Supplementary Tables 2) 
from the entire screen of 228 individually evaluated spheroids, describing features of single 
nuclei and global spheroid properties. By ranked based clustering of the results, we obtained 
5 clusters of knock-down phenotypes that correlate in their quantitative (Figure 19a) and visual 
features (Figure 19b-f). The negative control samples transfected with non-coding siRNA 
clusters together with LGR4, TCF7, TUFT1, WBP1 and CTSB (Figure 19 - cluster 1). This 
cluster comprises samples that were not or only slightly affected in their development and 
visual appearance. In comparison to the other clusters, these samples exhibited a high degree 
of growth represented in their growth rate by nuclei count, spheroid volume and high number 
of true transitions. These samples also displayed a high sphericity and migratory speed of the 
cells describing a highly vital phenotype.  
Cluster 2 (Figure 19 – cluster 2) includes samples with minor phenotypes with a strong focus 
on increased prophase size (LRP1, RAN, TOP2A and RGMA) and reduced spheroid volume 
(TOP2A and RGMA) (Figure 19c). 
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Cluster 3 (Figure 19d – cluster 3) comprises knock-down phenotypes with spheroids depicting 
an increased volume growth rate (LHFP, CDC6, CDCA5) and shorter cell phase transition 
times (MYC, CDC6) while exhibiting high degree of false cell cycle transitions (MYC, LMNB2, 
F11R). 
In cluster 4 (Figure 19e – cluster 4) strong phenotypes with reduced spheroid volume growth, 
reduced gain in nuclei count and low total number of cell cycle transitions (MEIS2, ATOH8, 
EME1 and CEP85) are grouped. 
The most distant cluster to the NC phenotype (Figure 19 - cluster 5) includes the positive 
control INCENP, as well as PLK1, MAP7, DSE, PRC1, BUD31, ESYT2 and AURKA. These 
samples showed aberrant phenotypes in up to seven statistically significant features (p-values ≤ 0.05), describing grave development malfunctions as well as cellular and mitotic defects. 
Most notably were defects in spheroid growth, mitotic arrests, false cell cycle transitions, 
macronuclei formation and apoptotic cells. In comparison to these strong phenotypes, cluster 
2-3 phenotypes comprise mainly singular or low statistical phenotypes (Figure 19a). 
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Figure 19 – Clustered phenotype analysis of all features detected in diSPIM HCS 
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Figure legend continued from previous page: a) Ranked based clustering of the phenotypes by their individual 
features describing the global and nuclei specific properties displays distinct clusters of siRNA target genes. b-f) 
Cluster 1-5 example images of each phenotype. Scale bar = 50 µm 
 
3.3.8 Detected phenotype in comparison to the MitoCheck online data base 
To evaluate the performance of our screening workflow and analysis pipeline, we compared 
the detected phenotypes to the online MitoCheck data base [148] (mitocheck.org), used during 
the planning phase of this project to select for the used target gene targets. In the MitoCheck 
screen only the first two to four cell divisions of HeLa H2B-GFP cells were imaged and 
analyzed for any abnormal phenotypes upon target gene knock-down. In comparison to the 
conducted high-content diSPIM screen, this results for the different MitoCheck screens in a 
focus on severe mitotic defects rather than on long-term development. Additionally, a 
heterogeneous population of cells was analyzed for the MitoCheck screen, whereas in this 
project we clonally expand a single cell and evaluate the single cell development. These 
differences in the two approaches on a high-content screen is reflected in the comparison of 
our results to the MitoCheck data base with a high degree of knock-down phenotype overlap.  
Notably, all of the strong and severe phenotypes identified in our study, such as complete cell 
cycle arrest, apoptosis, growth arrest and macronuclei formation induced by the knock-down 
of INCENP, PLK1, MAP7, DSE, PRC1, BUD31, ESYT2 and AURKA, described by Figure 14, 
Figure 15, Figure 16, Figure 17, Figure 18 and Figure 19 were also described in the MitoCheck 
screen even though a different cell line was used. Minor phenotypes such as the macronuclei 
formation in some spheroids induced by CEP85 and MEIS2 knock-down (Figure 19e) or 
interphase arrest induced by MYC siRNA transfection (Figure 19d) were not described. 
Additionally, TOP2a knock-down induced in our screen a higher ratio of prophase-classed 
segments, characterizing an elongated prophase. This phenotype was also identified by the 
MitoCheck screen, however in a validation experiment, a reduced prophase duration was 
described by the authors.  
 
3.4 Specific methylome modification and analysis of induced aberrant 
mitosis 
To confirm and evaluate the detected phenotypes of the siRNA-mediated knock-down diSPIM 
imaging screen, we modified the gene expression of our target genes by applying a molecular 
tool based on the recently described CRISPR-Cas9 system. This CRISPR-dCas9 methylome-
modifying effector domain fusion protein has been shown to modify the epigenome at a 
targeted genomic location defined by the sgRNA as introduced in 1.2.2.  
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3.4.1 Epigenetic modifiers as gene regulatory method 
We fused the catalytic C-terminal effector domains of epigenome modifying enzyme 
(DNMT3a, TET1) C-terminally to the dCas9 via a linker and added two nuclear localization 
sequences (NLS) for improved nuclear localization and a M2 flag to the N-terminus (Figure 
20a). A dCas9 with no C-terminal addition of an ED was used as binding control (Figure 20a) 
and to physically block binding sites for regulatory factors. The EDs originate from the 
catalytically active C-terminal domains of the respective methylome-modifying enzyme (Figure 
20b). We targeted the different epigenome modifying molecular tools to specific genomic sites 
by combining different sgRNAs with the different effector domains to modify distal or proximal 
regulatory CpGs with regulatory properties (Figure 20c). sgRNA target sites were selected to 
be approximately 33 base pairs away from the CpG to maximize epigenetic modifying 
efficiency following the results on methylome modifications by Vojta and colleagues [171]. 
Based on a 450k Illumina breast cancer patient screening data set comprising gene 
expression and CpG methylation data from human breast cancer patients, we selected CpGs 
that show high correlation (Pearson correlation > 0.5) between the expression of the selected 
target genes and the CpG methylation level (Figure 9 / Supplementary Tables 1). We detected 
up to seven regulatory CpGs per target gene (MEIS2 and RGMA) with correlative and anti-
correlative regulatory properties. From the bioinformatics side, we expected that correlated 
CpGs (low CpG-me results in reduced expression) would show a gene knock-down dependent 
phenotype when these CpGs were targeted by the TET1 dCas9-ED and induce a phenotype 
resembling tumorigenesis in breast cancer, as these CpGs are demethylated in breast cancer. 
Correspondingly, we expected anti-correlated CpGs (high CpG-me results in reduced 
expression) to show the abnormal mitotic phenotype, when targeted by the methyl-group 
transferring DNMT3A.  
Target genes that had only a single regulatory CpG with a correlation between expression 
level and CpG methylation below 0.6 were not further analyzed to focus our effort on most 
significant and promising target genes. Due to these restrictions, ATHOH8, AURKA, BUD31, 
CTSB, DSE, ESYT2, LGR4, RAN, and RBBP4 were not further investigated. 
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Figure 20 – dCas9-ED constructs targeting regulatory CpGs 
a) CRISPR-Cas9 based epigenetic modifiers and binding control were composed of a M2-flag (blue), two nuclear 
localization sequences (orange), the dCas9 (light gray) mutated at residue 10 and 840 (red) deactivating the 
endonuclease function of the Cas9, and the effector protein (green). The effector domains were fused C-terminally 
via a linker (dark grey). b) Effector domains are the catalytically active, C-terminal domains of DNMT3A and TET1 
from residue 1236 (DNMT3a) and 2059 (TET1) to the C-terminus of the protein. c) CRISPR-dCas9 fused with the 
effector domain was located to specific target sites defined by the sgRNA. dCas9-ED and sgRNA combination 
defined gene regulatory properties and targeted correlated or anti-correlated CpGs. Per CpG, we transfected two 
(upstream and downstream) sgRNAs with opposing orientation. CpGs were located in promotor and distal 
regulatory regions. 
 
3.4.2 The selected molecular tool for gene knock-down 
The remaining 18 target genes, had a total of 60 regulatory CpGs (mean Pearson correlation 
> 0.6), with 76% (n = 46) CpGs located in distal regulatory regions, while 23% (n = 14) CpGs 
are within 1 kb of the transcription start site. 42% (n = 25) CpGs show a positive correlation 
between methylation level and gene expression, while 58% (n = 35) are anti-correlated 
(Supplementary Tables 1). The genes CEP85, MEIS2 and RGMA were target genes that 
displayed correlated as well as anti-correlated CpGs making these targets highly interesting 
for quantitative analysis and epigenetic regulation comparison.  
SgRNAs directing the dCas9 effector domain fusion protein to the specific genomic site were 
designed to locate the methylome-modifying enzymes around on average of 33 base pairs 
upstream from their corresponding target CpG, since it was described by Vjota and colleagues 
[171] that the dCas9-ED shows highest epigenome modifying effectivity 27 bp (+/-17 bp) from 
the PAM sequence of the sgRNA. Per regulatory CpG, we designed two opposing sgRNAs, 
one binding to the sense and one binding to the anti-sense strand of the DNA. Furthermore, 
sgRNA target sites were checked to display a minimum of two mismatches to the next off-
target site, which should reduce off-targeting effects.  
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3.4.3 Control constructs to validate the methylome-mediated phenotype 
To verify the induced phenotype and relate the observed effect solely to the modification of 
the methylome rather than the binding of a large protein to a regulatory region, we included in 
the pre-screen a third construct, which was comprised of only the dCas9 protein without any 
further enzyme added to the C-terminus. This construct allowed us, to evaluate the effect of 
the binding of the dCas9 onto the target site and distinguish the effects caused by plasmid 
transfection, site-specific protein binding and the effective methylome modification.  
Furthermore, we wanted to induce and analyze a gene knock-down, through binding of the 
dCas9 to the transcription start site (TSS), a method in this thesis referred to as CRISPRi. We 
used the FANTOM5/CAGE online atlas (http://fantom.gsc.riken.jp/5/) to define the TSS of our 
target genes and selected a single sgRNA binding site at an average of 50 bp upstream of the 
TSS for optimal gene repression effect [70, 172]. 
 
3.4.4 Pre-screen in HEK293 cells 
MCF10A cells are highly susceptible to siRNA transfection, but showed even with specialized 
transfection reagents a strong resistance against transfection with plasmids, displaying a 
transfection efficiency of ~2% detected by GFP expression (Figure 21a). This made it highly 
problematic to introduce both the sgRNA and the protein component of the functional dCas9-
ED into this cell line by means of plasmid transfection for a statistically relevant quantitative 
analysis. We therefore decided to change to another cell culture model, the human embryonic 
kidney 293 cell line (HEK293). This cell line can be easily transfected with sgRNA expressing 
plasmids in comparison to MCF10A cells (Figure 21a). 
When we compared the regulatory CpG methylation levels available from the ENCODE data 
base between MCF10A and HEK293 cells, we detected a good average correlation (0.69 
Pearson correlation / 8.2% mean difference) of the target CpG methylation level between the 
two cell lines. Only individual CpGs displayed a larger than two-fold difference in the CpG-me 
(Figure 21b). Key differences were detected in the MEIS2 expression correlated CpGs, where 
four out of the seven regulatory CpGs showed a stronger decrease in methylation level in 
HEK293 cells than in the respective CpG in the MCF10A cell line. MEIS2 is a homeobox 
protein of the TALE (three amino acid loop extension) protein family involved in transcription 
regulation and shows a 47% higher transcription level in HEK293 cells in comparison to the 
MCF10A cell line (proteinatlas.org). This discrepancy of gene expression had to be considered 
for result evaluation of the MEIS2 target gene. In total, an increase in methylation level at a 
single CpG of more than two-fold was observed for CpGs regulating CDC6, F11R, FOXM1, 
MYC, TCF7 and PRC1 (Figure 21b).  
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To modulate the methylation level at the target CpGs in HEK293 cells, we introduced and 
selected for the stable expression of the different dCas9-ED constructs and evaluated the 
expression and localization of the recombinant protein by immunofluorescent staining (Figure 
21c). The stable cell line expressing the dCas9-ED fusion protein allowed us to introduce in 
the pre-screen only the sgRNA delivering plasmid, to complete the methylome-modifying tool.  
 
 
 
Figure 21 – HEK293 as model for epigenetic remodeling 
a) Average transfection efficiency of MCF10A and HEK293 of siRNA targeting PLK1 (light green) and a sgRNA 
control plasmids (light blue) for a minimum of 1,000 cells. b) Comparison of MCF10A CpG methylation level (X-
axis) to the ratio of the target CpG methylation level of HEK293 and MCF10A cell line (y-axis) for the different target 
genes and their respective regulatory CpG. The light grey area indicates changes in the methylation level less than 
2-fold. c) Immunostaining of HEK293 cells expressing the different dCas-ED molecular tool constructs (scale 
bar = 50 µm).  
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3.4.5 Selection of effective molecular knock-down tools 
Imaging by light sheet microscopy of the phenotype was not feasible, due to the extensive 
data that would have been generated with different combinations of the dCas-ED, dCas9 
control construct, and sgRNA combinations. To circumvent the generation of an 
unmanageable data set, and difficulties arising from 3D immunofluorescent staining of 
samples mounted in Matrigel we decided to select first for significant methylome regulated 
target genes, that showed an abnormal phenotype already in 2D HEK293 cells acquired by 
2D confocal microscopy. Subsequently, we would follow up with in depth analysis of the top 
target by means of high-content 3D live light sheet imaging.  
In this pre-screen, we combined a total of 129 sgRNAs targeting regulatory CpGs or TSS or a 
non-targeting control sgRNA with the two dCas9-ED constructs and the inactive Cas9 
construct stably expressed in HEK293 cells (Figure 21c). As before, we reduced transfection 
and handling artifacts by using solid-phase reverse transfection to deliver the sgRNA 
expressing plasmid into our dCas9-ED expressing cell lines. The sgRNA plasmid could be 
detected by GFP expression in transfected cells (Figure 21). SgRNAs that target correlative 
or respectively anti-correlated CpGs of a single target gene were mixed and transfected 
together, again to reduce the number of samples to 48 per dCas9-ED.  
Although we achieved high transfection efficiencies and used HEK293 that stably express the 
dCas9-ED or the dCas9 constructs, we additionally used immunofluorescent staining to 
validate the presence of the sgRNA and fusion construct in each individual cell, due to varying 
dCas9-ED expression levels, as seen in Figure 21c. If only a single component (sgRNA or 
dCas-ED) was detected within a single cell, this cell was considered as negative and was not 
used for quantitative analysis.  
We evaluated and classified the nuclear phenotype of double positive cells (++ / cells 
expressing dCas9-ED and the sgRNA) at different time points post transfection for up to 8 
days by deep learning classification (Figure 22). Nuclei classes comprised the four main 
stages of the cell cycle (inter-, pro-, meta-, anaphase) as well as two additional phenotypes 
that describe nuclear aberrations. These abnormal nuclear phenotypes were macronuclei and 
apoptotic condensed DNA. A macronuclei phenotype describes a relatively large nucleus, 
displaying polyploidy through cell cycle progression without mitosis, while ACD describes the 
chromatin condensation induced by cell death. These two prominent phenotypes were not 
included in the CNN classification of the diSPIM scree in 3.3, as not sufficient training data 
could be generated prior to the light sheet screen. Additional features such as nuclei size were 
furthermore calculated from the immunofluorescence images. A phenotype was considered 
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strong when a nuclei class or class segment size was 1.5-fold increased over negative cells 
or the control samples transfected with non-targeted sgRNA. 
 
 
Figure 22 – dCas9-ED pre-screen for distinct phenotypes 
a) dCas9-ED expressing HEK293 cells were transfected with sgRNA expression plasmids, completing the active 
fusion protein for methylome remodeling. Immunostaining for GFP (sgRNA) and M2-flag (dCas9-ED) allows to 
detect complete epigenome editing molecular tool present in the cell, while DNA was labeled by DAPI for b) 
segmentation and c) phenotype detection by CNN nuclei classification (scale bar = 5 µm). d) Subsequently, 
analysis detects significantly occurring phenotypes and calculated nuclei features.  
 
3.4.6 Correlation of phenotypes  
A total of 129 possible dCas9-ED-sgRNA combinations were evaluated with an average of 
6856 cells analyzed per combination, giving a total of 2.7 million nuclei that were evaluated in 
this pre-screen summarized in Table 3 for dCas9 genomic localization and in Table 4 for the 
different dCas-ED applied to target regions. 
We detected in a total 18% of all sgRNA-dCas9 combinations strong phenotypes (n = 23) with 
a feature / class increase of more than 1.5-fold in comparison to untransfected (-) cells of the 
same class. 30% (n = 7) of the detected phenotypes were caused solely by localizing the 
deactivate Cas9 to the DNA (Table 3). 43% (n = 10) of 1.5-fold increased phenotypes were 
detected in dCas9-TET1 targeting and 26% (n = 6) in dCas-DNMT3a expressing cells. 
Strong phenotypes included high ratio of apoptotic cells (ACD phenotype) (n = 4; 17%), 
macronuclei formation (n = 10; 43%), metaphase arrest (n = 2; 9%) and prophase arrest (n = 6; 
26%). Additionally, significantly larger macronuclei (n = 2; 7%) and prophase (n = 1; 4%) 
segments were detected in direct comparison to the untransfected cells.  
In conclusion, 88% of the CRISPRi and dCas9-ED evoked phenotypes (n = 22) matched in 
the described nuclei characteristics to the cells with the respective siRNA mediated gene 
knock-down described by the MitoCheck database or the Cyclebase3.0 [173] (Table 3, Table 
4). An additional 85% (n = 17) of the evoked targeted CRISPRi and dCas-ED phenotypes 
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were comparable described as result of the same target gene knock-down in the high-content 
light sheet microscopy screen (3.3), highlighted by the check marks in Table 3 and Table 4. 
 
Comparable phenotypes include an increase in macronuclei phenotype represented by an 
increase in nuclei size or high ratio of prophase. As discussed above (3.3.4), macronuclei 
phenotypes are often misclassified by the convolutional neuronal network as prophase in the 
high-content diSPIM knock-down screen. Severe phenotypes, such as ACD, cell cycle 
elongation or arrest and macronuclei formation correlate with reduced spheroid growth and 
reduced motility as these cells are strongly restricted in their capability to divide and overall 
viability. Furthermore, can a cell cycle arrest at a defined state also prevent proliferation, 
therefore result in a reduced spheroid growth or elongated cell cycle phase duration. 
Although not conclusively analyzed in their mode of action, the high correlation of phenotypes 
between the different methods of gene modulation show a high similarity between the outcome 
on the cell upon three different target gene perturbation. 
 
Table 3 – CRISPRi: evoking a phenotype by dCas localization to target site 
Listing of target genes that show more than 1.5-fold increase phenotype, such as apoptotic condensed DNA (ACD) 
and increase in cell cycle class upon dCas9 positioning (CRISPRi) to anti-correlated (cyan), correlated (magenta) 
regulatory CpGs or transcription start site (orange). Detected CRISPRi phenotypes were compared with online 
databases (CB: Cyclebase.org / MC: MitoCheck.org) and siRNA diSPIM screen results described in Chapter 3.3. 
To the CRISPRi comparable induced spheroid and mitotic phenotypes are highlighted by green check mark, 
correlating the methods. incr. = increased 
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Table 4 – Strong  phenotype induced by dCas9-ED targeting regulatory CpGs 
Listing of target genes that show more than 1.5-fold increase phenotype, such as apoptotic condensed DNA and 
increase in cell cycle class upon a) dCas9-DNMGT3a positioning (CpG methylation) or b) dCas9-TET1 positioning 
(CpG demethylation) to anti-correlated (cyan), correlated (magenta) regulatory CpGs or transcription start site 
(orange). Detected phenotypes were compared with online databases (CB: Cyclebase.org / MC: MitoCheck.org), 
CRISPRi phenotypes and siRNA diSPIM screen results described in Chapter 3.3. To the dCas9-ED comparable 
induced spheroid and mitotic phenotypes are highlighted by green check mark, correlating the methods. DCas9-
DNMT3 is expected to target anti-correlated sgRNA CpGs targets (cyan arrow) while dCas9-TET is expected to 
induce knock-down phenotype in correlated sgRNA CpGs targets (magenta arrow). incr. = increased 
 a) dCas9-DNMT3a site directed epigenome modification 
 
 
b) dCas9-TET1 site directed epigenome modification  
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To evaluate the effectivity of methylome modification, we compared the anticipated effect of 
dCas9-ED targeting correlated CpG, anti-correlated CpG and TSS targeting with the 
measured influence on the cellular phenotype. 50% (n = 6) of the twelve dCas9-DNMT3a 
(Table 4a) and dCas-TET1 (Table 4b) samples with elevated levels of elicited phenotypes, 
targeted CpG properties matched with the bioinformatically predicted gene knock-down effect 
of the methylome modulation. In an additional 4 cases the localization of the dCas9 to the 
transcription start site was sufficient to induce a knock-down phenotype. In the other 27% (n 
= 6) sgRNA and dCas9-ED combinations, the localization in theory would increase the 
expression of the target gene, while still inducing an anticipated knock-down phenotype. The 
underlying cellular processes and reasons these phenotypes evolve cannot be defined 
through the conducted experiments at this point and would need further evaluation and 
differentiated analysis of the effectivity, regulatory mechanisms and capability of the different 
dCas9-ED. 
 
3.4.7 In depth analysis of RGMA regulating dCas9-ED targets  
Subsequently to the conducted pre-screen, we focused on RGMA for a in depth analysis, as 
this gene showed as only target after different methylome modifications a significant, 
predictable and reproducible phenotype (Table 4a, b) correlating in the evoked macronuclei 
phenotype with the online data bases and siRNA mediated segment size increase in the HC 
light sheet siRNA screen. MitoCheck.org describe the RGMA phenotype as strange nuclear 
shape, with nuclei segregation problems and multiple DNA masses, a phenotype that was 
detected as macronuclei class by the deep learning nuclei classifier. Additionally, RGMA is 
highly interesting to study the effectivity and possibilities of targeting different effector domains 
with different properties to defined target CpGs, as RGMA has both, correlated and anti-
correlated CpGs (Supplementary Tables 1). 
The RGMA (Repulsive Guidance Molecule Family Member A) gene encodes a 
glycosylphosphatidylinositol-anchored glycoprotein that has a known function as an axon 
guidance protein in the developing and adult central nervous system. For RGMA we detected 
a total of seven regulatory CpGs, three with correlated and four with anti-correlated regulatory 
properties.  
These regulatory CpGs displayed a high correlation of the methylation level between HEK293 
cells and MCF10A cell lines (Pearson correlation: 0.86) (Figure 21b), giving evidence that the 
different means of RGMA gene knock-down can be directly compared in the different cell lines. 
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When further evaluation the RGMA knock-down phenotype in the conducted pre-screen, we 
detected in three dCas9-ED-sgRNA combinations a high ratio of the cells the macronuclei 
phenotype targeting the TSS, correlative and anti-correlative RGMA regulatory CpGs (Table 
5 / Figure 23b). On average the segment sizes increase by 2.2-fold in the evoked macronuclei 
from 1229 pixels to 2739 pixels (dCas9-DNMT3a targeting anti-correlated CpGs) or by 3.3-
fold to 4111 pixels (dCas-TET1 targeting correlated CpGs) respectively, when compared to 
interphase classed nuclei. The increase in nuclei size and the macronuclei phenotype induced 
by the different sgRNA-dCas9-ED combinations are depicted exemplary in Figure 23. 
Furthermore, the ratio of the macronuclei class increased significantly when anti-correlated 
CpG targeting sgRNA with dCas9-DNMT3a was present in the cells increasing the 
macronuclei count by 56%. dCas9-DNMT3a targeting the TSS mediating CRISPRi increased 
the ratio of macronuclei class segments to 1.94-fold (Table 5). dCas9-TET1 failed to 
significantly increase the ratio of macronuclei found in double positive and negative cells, 
resulting in a 1.36-fold increase of the occurrence of the macronuclei class.  
Finally, to validate the obtained the results, we used any of the highly effective dCas9-ED 
constructs and combined these with a non-targeted sgRNA. In these samples, we could not 
detect a significant difference between double positive and negative cells in class occurrence 
or size increase (Table 5 – non-targeted control). Some sgRNA-dCas9-ED combinations even 
achieved a reduction of the macronuclei class ratio (Table 5 – dCas-TET1 and dCas9 
combined with non-targeted sgRNA).  
 
Table 5 – RGMA is an effective dCas9-ED target 
In-depth comparison of the effect on the macronuclei class by the different active dCas9-ED targeted against 
regulatory elements of the RGMA gene. As control a non-targeted sgRNA was used in combination with all dCas9-
ED. Asterisks labels ratio below 1.5-fold increase between double positive and untransfected cells. Red highlights 
a decrease of the macronuclei class ratio, Occurrences of the macronuclei class depicts ratio of samples 
comprising the phenotype class to total sample count. 
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Figure 23 - RGMA knock-down phenotype in 2D 
a) Screen images of RGMA knock-down in HeLa cells (MitoCheck.org). b) Example images of phenotypes evoked 
in 2D HEK293 cells upon dCas9-ED localization to anti-correlated (cyan), correlated (magenta) regulatory CpGs 
as well as the TSS (orange).  
 
3.4.8 RGMA regulating CpGs targeted in 3D spheroids 
HEK293 cells seeded in Matrigel can develop into multi cellular spheroids, just like MCF10A 
cells described in 1.1.6. This trait of the HEK293 cells allowed us to study the RGMA knock-
down phenotype after methylome modification in 3D under the more physiological growth 
conditions. We therefore used the same sample preparation approach as described in section 
3.2.3, transfecting into the different dCas9-ED cell lines the sgRNA by plasmid solid-phase 
reverse transfection and mounting the cells subsequently in matrigel onto diSPIM one-well 
imaging plates. Three and five days after sgRNA plasmid transfection, we imaged every GFP 
positive (sgRNA positive) spheroid at low temporal resolution. We evaluated the nuclear 
phenotype and spheroid development over time (Figure 24 / Table 6) through Hoechst 
staining. As the dCas-ED fusion protein were not fluorescently labeled, we were not able to 
detect expression levels of these recombinant proteins. 
Similar to the prior conducted experiment, we combined the dCas9-DNMT3a with sgRNAs 
targeting anti-correlated CpGs and the TSS as well as, dCas9-TET1 with sgRNAs targeting 
correlated CpGs as these combinations resulted in a strong phenotype in the pre-screen 
a)
H2B-GFP
MitoCheck:	RGMA	
knock	down	in	HeLa
dCas9-DNMT3a	x
anti-correlative CpG
dCas9-TET1	x
correlative
dCas9-TET1	x
TSS
b)
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(Table 5). Furthermore, we combined the dCas9 without any effector domain with sgRNAs 
targeting either correlated, anti-correlated CpGs or the TSS as control.  
A total of 273 spheroids were imaged by diSPIM light sheet microscopy and evaluated for all 
of the following properties, resembling the same phenotypes described in 3.4: macronuclei 
development, extended mitosis duration (mitotic arrest), reduced growth and ACD 
development.  
The macronuclei phenotype was detected in ~40-50% of all spheroids, that either combine the 
dCas9-DNMT3a with sgRNA targeting anti-correlated CpGs (Figure 24a), dCas9-TET1 
targeting correlated CpGs (Figure 24b) or through positioning the dCas9 and dCas9-DNMT3a 
to the TSS (Figure 24c,f). When the dCas9 control fusion protein was targeted to regulatory 
CpGs, we could not detect a high number of spheroids, incorporating macronuclei (Figure 
24 d, e) with 5.6% and 7.4% of all spheroids showing macronuclei properties. Likewise, the 
phenotype of reduced growth and dying cells were distributed (Table 6), resembling a severe 
effect on the cellular homeostasis upon provisional RMGA knock-down. Elongated mitosis or 
mitotic arrest was detected in every third spheroid of dCas9-TET1 targeting correlated CpGs.  
 
Table 6 – Phenotype analysis of dCas9-ED targeting RGMA regulatory CpGs in 3D HEK293 spheroids 
For different sgRNA-dCas9-ED combinations targeting RGMA regulating CpGs and transcription start site (TSS), 
we replicated the pre-screen (3.4.4) in 3D spheroids and compared the effect of dCas9-ED targeting on different 
phenotypes. We evaluated the percentage of spheroids displaying abnormal cellular and global properties, such 
as macronuclei formation, extended mitosis duration, reduced spheroid growth and apoptotic cells (ACD). Example 
images for each combination are displayed in Figure 24. 
 
 
 In total, these results constitute the bioinformatically predicted target gene knock-down upon 
site directed regulatory CpG methylation modulation and the resulting manifestation of the 
knock-down phenotype in macronuclei formation describing for the RGMA regulatory CpG an 
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effective possibility to regulate RGMA gene transcription. For RGMA, the conducted 
experiments strongly correlate the phenotypes to the suppression of the target gene 
independent of the applied method allowing a provisional correlation and comparison of the 
evoked phenotypes between the different methods and different cell lines. 
For all methods modulating RGMA gene expression either on a transcriptional level by 
modulating regulatory CpGs with dCas-ED, or on the translational level through the siRNA, 
the evoked cellular phenotype represents a macronuclei formation resulting from incomplete 
cytokinesis while replication of the genome is continued, resulting multiple copies of the 
genome in a single cell.  
 
 
Figure 24 – Phenotypes evoked by dCas9-ED targeted against regulatory CpGs in 3D 
Example images of HEK293 spheroids grown in Matrigel after dCas9-ED-sgRNA targeting regulatory CpG. a) Anti-
correlated CpG targeting sgRNA (cyan) combined with dCas9-DNMT3a. b) Correlated CpG targeting sgRNA 
(magenta) combined with dCas9-TET1. c) TSS targeting sgRNA (orange) combined with dCas9-DNMT3a. d) anti-
correlated CpG targeting sgRNA (cyan) combined with dCas9. e) correlated CpG targeting sgRNA (magenta) 
combined with dCas9. f) TSS targeting sgRNA (orange) combined with dCas9 (scale bar = 50 µm). 
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4 Discussion 
In this project, we developed the methodological framework to study spheroid development 
and subcellular phenotypes in 3D cell culture systems in great depth and large number upon 
a perturbation. First, we established light sheet microscopy as tool to image 3D spheroids in 
a high-content screen at unmatched spatial and temporal resolution. Second, we used this 
method to analyze siRNA-mediated knock-down phenotypes in spheroids in a highly 
automated fashion. Third, we compared the siRNA and epigenetic methylation regulatory 
methods for target gene knock-down and the evoked phenotype. Thereby, we were able to 
compare usability, effectivity, and the induced phenotype between the two molecular methods. 
 
4.1 Light sheet microscopy as a method for 3D cell line imaging 
Image-based phenotype analysis is a very established method and has already been used 
extensively in imaging-based screens to detect abnormal phenotypes in cell culture systems 
upon molecular perturbations [126] or drug administration [7, 160]. Key applications of these 
screens can be found in pre-clinical trials in search for novel, effective inhibitor molecules and 
selection of potential treatment targets, as well as in basic research, analyzing individual gene 
functions or the functional interplay of associated genes.  
For many years, spinning disc microscopes were the state-of-the-art system applied in these 
imaging screens due to their superior speed and low light dose in comparison to laser scanning 
confocal microscopes [7, 131, 174, 175], while retaining confocality and image resolution. For 
any imaging application in 2D cell culture models, the SDM or CLSM systems provide an 
effective, easy, usable, and established platform with sophisticated microscope controls and 
optimized incubation appliances. However, all single objective confocal microscopes display 
a major problem with larger samples such as 3D spheroids and organoids. Due to light 
scattering as photons pass through the tissue, these systems are not able to provide isotropic 
resolution deeper within larger tissues (Figure 5). SDM and CLSM systems are not able to 
image the entirety of the 3D cell culture model at high resolution and are restricted to cellular 
analysis on the surface or outline of the specimen. Additionally, acquisition times of seconds 
to minutes restrict high-throughput applications, short imaging intervals and large sample 
count, while intensive light exposure can induce phototoxic effects (Table 1).  
With the commercial development of light sheet microscopes with an inverted geometry such 
as the ASI diSPIM system [112] or the Luxendo QuVi system, the advantages of light sheet 
imaging are now applicable to standardized 3D cell culture formats. Other light sheet 
microscopy geometries such as the multi view SPIM developed by Keller and colleagues [104, 
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176] allow high spatial resolution of large specimens, but lack capability to image more than a 
few samples. Asymmetric light sheet technology implementations such as developed by 
Strnad and colleagues [115] enable acquisition of up to 20 samples but are labor intensive 
and challenging to mount as well as restricted in their in-depth imaging capabilities, making 
the upright, dual-view geometry of the diSPIM the most suited system for high-content 3D cell 
culture imaging (Figure 4).  
Dual view light sheet imaging is, as we have shown, an ideal light sheet geometry to acquire 
3D spheroids with a size up to 100 µm at high temporal and isotropic spatial resolution (Figure 
8). The extremely fast acquisition capabilities of the diSPIM allow a high sample number to be 
imaged at extremely short acquisition intervals (Figure 10). The low light intensity needed to 
provide sufficient signal to noise ratio allows imaging with an undetectable phototoxic effect 
on the sample. Dual view acquisition combined with image fusion and 3D deconvolution 
provides unmatched image quality as well as high, isotropic resolution, with the second view 
compensating for in depth light scattering (Figure 11). In summary, the light sheet microscope 
outperforms the spinning disc microscope in almost every measurable imaging parameter 
(Table 1) and cell viability experiment (Figure 8). 
The ASI diSPIM system displays exceptional performance when handled correctly, but 
usability was restricted by user experience. Further challenges of the diSPIM such as imaging 
stability, sophisticated incubations, data size, and data processing were addressed by us and 
improved to a stage, where the entire development of a spheroid from a single cell could be 
imaged without influencing the development (Figure 8). Acquired data was instantly reduced 
by ~75% through image processing by the hSPIM diSPIM data processing tool, which uses 
state-of-the-art local, parallel GPU processing hardware for maximal performance and 
throughput (Figure 11). This allowed usage of standard IT infrastructure for data transfer in a 
reasonable time frame. Major limitations of the diSPIM system in 3D spheroid acquisition were 
only posed by samples larger than 100 to 120 µm in diameter. These samples outgrew the 
FOV quickly and loss in isotropic resolution was detected due to single view in depth signal 
loss.  
 
4.1.1 Automation and reproducibility 
Our key focus throughout the establishment of the high-content screen was on a high degree 
of reproducibility within the screen and for any possible future imaging application. This meant 
a high degree of automation while retaining flexibility to use different 3D cell culture systems 
and methods of cell culture perturbations. Additionally, any software used in this project was 
open source, with processing workflows quickly adaptable to the individual project focus. 
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With the usage of solid phase siRNA reverse transfection and the liquid handling robot we 
achieved high transfection rate, high precision sample mounting and strong reproducibility of 
the sample preparation minimizing individual human impact. This allows future research to 
apply the developed methods instantly on other cell lines and perturbation methods. 
Additionally, we implemented a pre-screen step to autonomously select samples for 24 hours 
imaging. Not only did this step reduce manual labor in sample selection, but it also provided 
an impartial selection of the spheroid with the only factors that define the sample selection 
being the position in the Matrigel, bypassing any 2D cell layers at the bottom of the dish and 
fused spheroids originating from two consolidated cell clusters. 
 
4.1.2 Optimizing acquisition for a high-content screen  
The fast imaging capabilities and low phototoxic effects of the light sheet microscopes entice 
for excess acquisition of unnecessary data. This can be due to unnecessarily short acquisition 
intervals or excess data covered by only a single view such as produced for small samples by 
the stage scan acquisition. Though possibly not affecting the sample viability, a key focus of 
light sheet microscopy should always be data reduction through data restricted acquisition. 
This will facilitate data handling and shorten data processing time and processing performance 
demand.  
In this project, we therefore assessed every aspect of the screen in regard to data reduction. 
We selected piezo/slice acquisition due to the higher ratio of dual view acquired volume in 
comparison to stage scan acquisition, and for simplified post-acquisition data processing, as 
no deskewing of the data was necessary (Figure 4). Premises for the piezo/slice acquisition 
were the sphericity with a spheroid diameter of at most 100 µm and a confined single position, 
provided by five day old MCF10A spheroids.  
For larger samples beyond 100 µm in width, the optimal acquisition mode is stage scan 
acquisition as it reduces movement of mechanical parts during acquisition and is not limited 
in the stack size by piezo motors, but by the size of the sample. Additionally, imaging speed 
is not limited by microscope mechanics but by camera acquisition capabilities, outperforming 
the SyncA image acquisition by five-fold (Figure 4). Due to skewing of the data, XY pixel 
positions cannot be correlated directly and dual view registration and deconvolution would 
require additional image processing. We utilized this acquisition mode in the low-resolution 
pre-screen, since the aim was to detect a spheroid and its position within the imaging plate 
and not to provide high resolution image quality, which would have required dual view 
acquisition and image registration.  
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The number of acquirable samples during the high-content screen was defined by different 
factors restricting the acquisition speed of the microscope. Stage velocity, data transfer rate, 
and set-imaging parameters defined the acquisition duration per position scan of 4-5 seconds. 
We decided to acquire at three-fold oversampling, since this would support the highest spatial 
resolution, but also increase dual stack acquisition duration. Furthermore, we were limited in 
the stage velocity, as rapid accelerations and decelerations would have resulted in detaching 
of Matrigel spots from the imaging plate. Thirdly, with 1 GB of data acquired every four to five 
seconds, a reliable fast data transfer was essential. Standard local area network performances 
of ~100 MB per second were not sufficient to directly transfer the data onto a server, which 
again highlights the hardware demands and needed infrastructure always required for light 
sheet imaging. With the set imaging parameters and maximal mechanical movements of the 
different stages, we were limited to 40 positions imaged every five minutes. The high temporal 
resolution was essential to track single cells throughout cell division (Figure 11).  
 
4.1.3 Separating beads and samples for image processing 
With multi view imaging, acquired data has to be conjoined through image registration and 
fusion of the different views. Two main methods have been used in the community for image 
registration. In contrast to signal or content based multi view registration detecting local 
intensity maxima within the sample, the registration matrix detection based on single 
fluorescent beads is independent of fast, dynamic intensity changes within the sample as seen 
during cell mitosis as well as intensity differences between the different views. Furthermore, 
bead based registration does not require a large sample with variations of signal intensities, 
but can be performed on single cells, the only requirement is the acquisition of beads in the 
sample or in a separate acquired position. Additionally, the PSF can be extracted from an 
image stack displaying beads for all acquired views. Bead based registration and 
deconvolution allows to applying the PSF directly to the processed image and compensates 
for minor optical aberrations in the detection path, as these are also affecting the PSF and 
therefore deducted from the output image. 
A standard approach in multi view SPIM imaging with bead-based registration would be to mix 
fluorescent beads into the mounting gel of the sample. In this project, we physically separated 
beads from the sample and imaged stacks of beads immersed in Matrigel separately, which 
allowed us to detect registration matrix and PSF independently from any sample. We then 
applied these factors onto all other samples acquired at the same acquisition interval, without 
impairing image quality by high signal beads within the sample (Supplementary Figure 2). 
Furthermore, this meant that the registration matrix only needed to be calculated once per 
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time point, reducing computational demands drastically. Additionally, minor optical artifacts in 
the detection path induced by a small shift in refractive index between culture medium and 
Matrigel were compensated for, as the PSF was not theoretically calculated from the 
wavelength and objective properties but was extracted from imaging data. This improved 
overall image quality in long-term acquisitions, as minor shifts in the excitation and detection 
path originating from microscope de-alignment were compensated for. Additionally, 
registration matrix and PSF can be transferred between different color channels illuminating 
other fluorophores as used in Figure 8 with only minor increase in image blurring, again 
reducing required calculation steps in image processing. Additionally, we were not able to 
purchase fluorescent beads with sufficient signal and required bead size for the blue (405 nm) 
channel primarily used for DAPI / Hoechst (nuclei) staining. The transfer of PSF and 
registration matrix from the green channel (488 nm) to the blue (405 nm) channel allowed us 
to process the short wavelength (blue channel) data in Figure 24. The missing chromatic 
correction of the objective in the short wavelength range did not alter the image quality 
significantly. 
 
4.1.4 High-throughput image processing 
Besides simplifying sample preparation and imaging, we additionally focused on facilitating 
image processing (Figure 11). The established pipelines where developed for processing of 
any large diSPIM data while remaining open-source throughout. In the future, this developed 
workflow will allow any dual view light sheet user to easily process their own data without the 
need to script their own image processing pipeline, a major hindrance and concern for 
researchers to use the novel light sheet technology.  
 
4.1.5 Image classification by deep learning 
Grouping of individual images or subparts of an image, called image classification, is a key 
component of any quantitative image analysis [140, 177, 178]. We compared the effectivity of 
classical machine learning methods (random forest) to the novel convolutional neuronal 
network image classification methods (Figure 12). In terms of accuracy and processing speed, 
the used CNN classifier outperforms the RF classification significantly. On the other hand, 
CNNs provide the challenge to generate a sufficient sized training data set with appropriate 
but diverse sample images. These large data sets need to be generated a priori and with 
accurate selected data, in order to train the CNN to perform accurately. Additionally, CNN 
properties and setup have to match the application, as shallow networks tend to be inaccurate 
while deep networks require too much computational performance [151, 178]. Additionally, 
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empirical knowledge on CNN application in life science and microscopy data analysis is 
restricted, resulting in a trial-and-error approach to CNN implementation in the analysis 
workflow. On the other hand, demands of an imaging screen analysis of high-throughput und 
high accuracy with strong robustness towards minor imaging artifacts, signal loss, and image 
noise are met exceptionally by CNN image classification as seen in the results of this project 
(3.2.5). We believe that any future image segmentation, processing, classification, and 
analysis will be done using CNN as they provide strong performance improvements in 
comparison to classical image processing tools. 
 
4.1.6 Phenotype assessment through feature evaluation  
This project was conceived as a proof-of-concept and evaluation of different methods in gene 
regulation, phenotype imaging, and analysis. Therefore, we selected target genes on the basis 
of correlative knock-down methods (Figure 9). We aimed to induce gene knock-down on a 
transcriptional level through methylome modulation and on a translational level with siRNA to 
be able to compare effectivity and phenotype of these two molecular methods. Throughout, 
we focused on genes involved in the cell cycle, as gene regulation highly influences cell cycle 
progression, the role of mitosis in cancer initiation and cellular development [179, 180]. We 
set a high threshold on plausible effectivity of the knock-down, described by strong knock-
down phenotype and high correlation of CpG-me and gene expression, resulting in 28 possible 
target genes (Supplementary Tables 1). Due to the fact, that we only selected for genes with 
a known knock-down phenotype allowed us to compare the detected results for all methods 
of gene expression reduction to known phenotypes provided by online databases such as 
MitoCheck and CycleBase.  
Upon knock-down of the target genes by siRNA, we analyzed the phenotype by a total of 23 
features that describe both global spheroid features, as well as features describing the single 
nucleus (Supplementary Tables 2). This combination of quantitative features allowed a 
comprehensive understanding of single nuclei and their underlying characteristics as well as 
the context of the spheroid as a global growing tissue by analyzing spheroid growth, 
development in reminiscence of the induced phenotype. 
The negative, non-coding transfection control siRNA used as reference throughout this project 
showed even under the established high-content sample preparation and imaging conditions 
a close to normal development of the five-day old spheroid growing in Matrigel clonally from a 
single cell (Figure 8). The siRNA transfection as well as the described low phototoxicity of the 
diSPIM system did not interfere significantly with the development of the spheroid even when 
imaged at high temporal and spatial resolution. 
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The positive siRNA transfection control targeting INCENP allowed to evaluate the high 
efficiency of the sample preparation and HCS as we could detect and compare the knock-
down phenotype of INCENP in all acquired samples. The macronuclei phenotype detected by 
the large segment size, reduced growth and abnormal cell cycle progression with elongated 
mitotic phases is highly reminiscent with the described gene function in the chromosomal 
passenger complex and knock-down phenotype of INCENP [134, 181-183]. The macronuclei 
formation originates as described and detected in the HCS images through the inhibited 
cytokinesis while the cell enters repeatedly the mitosis as the correct chromosome alignment 
and segregation is misregulated through the loss of function of the chromosomal passenger 
complex. In the INCENP samples, we always detected two separate macronuclei (Figure 19). 
We postulate that after knock-down sufficient functional INCENP protein remained in the cell 
to complete one additional mitosis with completed cytokinesis.  
Other strong knock-down phenotypes of PLK1, MAP7, DSE, PRC1, BUD31, ESYT2 and 
AURKA such as found in cluster 5 (Figure 19) all resulted in significant growth reduction 
through mitotic arrest or prolongation that we were able to detect and quantify by the cell cycle 
analysis, nuclei and spheroid size and growth as well as global feature descriptors (Figure 
14 - 19). These phenotypes strongly resemble in their key elements the described phenotypes 
of the used online databases (genecard.org, MitoCheck.org, cyclebase.org) as well as match 
with known gene functions as discussed below.  
PLK1 is a serine/threonine-protein kinase, which plays an essential role in centrosome 
maturation and spindle assembly as well as the removal of cohesins from chromosome arms 
[184]. A knock-down of PLK1 is known to arrest the cell cycle in prometaphase [134, 148] 
which was described in the HCS by significant increased pro- and metaphase occurence, 
growth arrest and increased abnormal cell cycle transition (Figure 19). 
MAP7, a microtubule-associated protein with a known function in microtubule stabilization, 
microtubule function regulation as well as cell polarization is key in the cell cycle as the correct 
distribution of the chromosomes to the daughter cells relies on the microtubule spindle 
apparatus [185, 186]. We postulate, that the loss of MAP7 proteins in the cell could result in a 
loss of cell polarization prior to the distribution of the chromosomes to the cell poles as well as 
uncontrolled chromosome segregation resulting in loss or gain of chromosome number 
subsequent to the cell division. This hypothesis is underlined by the strong increase of the 
prophase duration as the cell potentially struggles to polarize and form the spindle apparatus 
(Figure 14). 
PRC1 or Protein Regulator of Cytokinesis 1 is a key regulatory protein of cytokinesis and 
spindle formation. PRC1 functions in cross-linking antiparallel microtubules and shows 
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essential functions of defining the spatiotemporal formation of the mid-body. Without the mid-
body defining the region of final separation of the daughter cells, a completion of the mitosis 
is not possible [187]. These two functions have been detected by the siRNA HCS as we found 
a strongly increased ratio of nuclei segments classified as pro- and anaphase (Figure 14, 
Supplementary Figure 6) while samples also failed to grow describing an arrest of the cell 
either at prophase or in the final stage of cytokinesis.  
BUD31 or Functional Spliceosome-Associated Protein 17 has a described function in mRNA 
splicing, an essential step of mRNA maturation and protein synthesis. A loss of all protein 
synthesis in a cell has a dramatic effect on the cellular homeostasis as all cellular processes 
rely on new synthesis of functional proteins due to constant protein turnover [188]. Loss of 
BUD31 results in fast loss of many mitotic proteins as these proteins display a higher turnover 
rate resulting from cell cycle stage specific expression in comparison to other housekeeping 
genes in frequently dividing cell culture model systems. Loss of growth and cell cycle 
progression detected in the HCS (Figure 18) can be the plausible result of mRNA maturation 
defects. 
AURKA or Aurora Kinase A is a serine/threonine kinase with a well-known function in 
regulating the cell cycle. It establishes the mitotic spindle apparatus, induces centrosome 
duplication, centrosome separation as well as maturation. AURKA is essential for 
chromosomal alignment in metaphase, as well as the separation of the daughter cells [189]. 
The detected increased number of all mitotic stages (Figure 14) as well as reduced growth 
capabilities of the samples (Figure 18) allows us to postulate and correlate a complete delay 
of the different steps of mitosis to the function of AURKA in all mitotic phases.  
ESYT2 or Extended Synaptotagmin 2 forms tethers to bind the endoplasmic reticulum to the 
cell membrane but has not been described directly to be associated with the cell cycle or 
mitosis [190]. Also, DSE or Dermatan Sulfate Epimerase has no close relation with the cell 
cycle as it functions as tumor rejection antigen with a specific catalytic function of converting 
D-glucuronic acid to L-iduronic acid during the biosynthesis of dermatan sulfate [191]. 
Downstream associations of DSE or ESYT2 with a specific step of the cell cycle cannot be 
excluded, that could explain the detected reduced growth and prophase arrest, but further 
functional experiments need to be conducted.  
In total, we can correlate in almost all analyzed target genes of cluster 5 the known and 
published gene function with the detected knock-down phenotype, with the exception of 
ESYT2 and DSE. These results highlight the capabilities of the conducted HC screen. In 
comparison to published screens such as the MitoCheck consortium, the 3D cell culture 
models and the light sheet imaging methods provide a more detailed, sensitive and reliable 
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insight onto the target gene function and the knock-down effect onto the phenotype (3.3.8). 
Subtle heterogeneity among evaluated cells in terms of knock-down level and genomic 
heterogeneity in the cell culture model resulted in distinct phenotypes even within a single 
spheroid. This shows the strong and sensitive capability, this screening setup provides to 
study intercellular heterogeneity upon treatment, while also providing conclusive insight into 
the gene knock-down.  
 
4.2 Knock-down using epigenome modifying molecular tools 
A siRNA gene knock-down allows for efficient gene function evaluation, but it is usually 
unresolved how the different methods can influence the readout of gene function and whether 
novel methods can compete in effectivity and usability with established siRNA knock-down 
approaches. Additionally, the mode of action of the molecular tool, targeting the transcription 
or translation of the gene, can allow for compensating mechanisms. We therefore compared 
the detected phenotypes induced by siRNA-mediated gene knock-down to a novel, CRISPR-
dCas9-ED based regulatory molecular tool, as well as compared their practical properties.  
The deactivated CRISPR-Cas9 protein targeting enzymatic effector domains towards defined 
genomic regions allows the genomic site directed application of many different effector 
domains with their defined molecular functions. Site directed modification of the epigenome 
allows potentially lasting modifications of epigenetic properties of the cell, as the epigenome 
is like the genome highly conserved even throughout cell division to retain cellular properties 
and characteristics [82, 192]. 
Problematic in this experimental design is the lack of definite knowledge on regulatory 
mechanisms, feedback between genome and epigenome and how the dCas9-ED is capable 
of influencing the cellular homeostasis [44, 53]. Furthermore, additional or novel compensating 
mechanisms cannot be excluded. Bioinformatic analysis on one hand allow to detect the 
connection between CpG methylation level and gene expression, as well as description of 
other features of the target site such as regulatory factor binding sites or 3D genome 
interactions [193]. But on the other hand, complex regulatory mechanisms, cellular feedback 
cycles, low method effectivity or off-target effects of the CRISPR-dCas9 protein can render 
straightforward theoretic approaches ineffective [52, 194, 195]. 
To date, many different applications of the deactivated CRISPR-Cas9 targeting different 
effector domains such as DNMT3a [61, 171], TET1 [62, 63], Krüppel-associated box (KRAB) 
repressor [196-198] and p300 core protein [93, 196] have been used to modify the epigenome 
while the direct comparison to siRNA-mediated gene regulatory methods are excluded from 
these studies. In this project, we directly compared the effect of both molecular methods on 
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the cellular development focusing on the used set of mitotic target genes. This enabled us to 
evaluate siRNA and dCas-ED site directed targeting in their effectiveness and applicability. 
To detect the methylome modifications and provide the highest success premises, we opted 
to provide the best prerequisites for the experiment. Therefore, we decided to change into 
another cell culture line and conducted a 2D pre-screen to define the most effective effector 
domain and target CpG combinations. The change of model system on the other hand also 
had an impact on the comparability of the evoked effect on the cell and made any correlation 
more questionable. Comparison of methylation level and target gene expression partly can 
compensate the unknown influence of the exchange of the used cell line.  
With the different CRISPR-dCas9-ED stably expressed in HEK293 cells, we could combine 
the active methylome-modifying molecular tool (sgRNA and dCAs9-ED) by simple and 
effective sgRNA expressing plasmid transfection. Developing the same experimental setup in 
MCF10A cells was not easily feasible as well as labor intensive, as this cell line is resilient to 
plasmid transfection and gene integration requires lentiviral transduction of the MCF10A cells 
(Figure 21).  
Through combining different sgRNAs targeting CpGs with identical regulatory properties 
(correlated and anti-correlated CpG methylation and target gene expression level), we 
diminished the individual effect of a CpG methylation modification, but on the other hand we 
also reduced the number of samples to be studied (Table 5 / 3.4.1). Effective sgRNA 
transfection into the established dCas9-ED cell lines, high-throughput image acquisition, and 
image analysis based on deep learning classification allowed for an effective evaluation of 
many different phenotypes in comparison to untransfected cells (3.4.4). Additionally, we 
compared the dCas-ED with the sole localization of the dCas to a target site perturbation 
(Table 3).  
 
4.2.1 Epigenetic modulation detected by cellular phenotype 
In total, we detected only in few (18%) sgRNA-dCas9-ED combinations a strong phenotype 
evoked by dCas9-ED targeting against the genome. All of these evoked, strong, abnormal 
nuclear shapes have been described by online databases or match with results obtained in 
the conducted HC siRNA screen, when the same gene was targeted by different means of 
modulation. 
In 30 % of these cases, a binding of the dCas9 without any effector protein to the regulatory 
site or TSS was sufficient to induce a knock-down phenotype (Table 3) describing the potential 
of CRISPRi. We presume, that binding of the dCas to the genome is on its own capable to 
prevent regulatory proteins from DNA binding at this regulatory domain.  
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Furthermore, we were successful in applying the different dCAs9-ED to induce a significant 
mitotic aberration that correlate strongly with the known (online data base) and in this project 
described (siRNA HCS utilizing light sheet imaging) phenotypes with very high correlation.  
These results provide the assumption that knock-down of the target gene was successful, 
especially for RGMA but also for other target genes. 
On the other hand, 12% of the phenotypes were evoked with sgRNA-dCas9 combinations that 
theoretically should not be able to have an effect on the methylome and therefore should not 
induce abnormal phenotypes in these cells.  
In conclusion, the methylome modification 2D pre-screen did not display adequate effectivity 
of the dCas-ED comparable to other established methods such as siRNA in inducing target 
gene knock-down phenotypes. CRISPRi, the localization of a large protein to a genomic 
domain deregulating this region shows high effectivity in comparison to the desired effect of 
methylome modulation. Underlying effects of the site-specific methylome alteration need 
further evaluation as well as regulatory mechanisms, that compensate the potential loss of 
gene expression. Potentially, each individual regulatory CpG needs to evaluated separately 
for dCas9-ED mediated deregulation. Furthermore, the obtained results reflect and highlight 
the key concern of the different described dCas9-ED molecular tools named in 4.2. The 
dCas9-ED have been first postulated in 2013 and established now for several years. The 
fusion of a large effector domain to a 160 kDa sized dCas protein results in a large protein that 
is questioned to be transported into the nucleus [199]. Furthermore, sophisticated delivery 
systems that avoid the transfection of two components into a single cell are being tested and 
slowly established but do not exhibit the efficiency of well-established molecular perturbations 
yet. Additionally, the biggest concern to date is the detection and evaluation of off-target 
effects. For gene knock-down studies the novel dCas9-ED tool as shown cannot compete in 
effectivity, usability and reliability with a siRNA knock-down, yet.  
In total, we must conclude that we were able to evoke upon targeted gene deregulation with 
both used methods the same visual phenotype in almost all samples with strong knock-down 
phenotypes, but experimental difficulties and limited understanding of the molecular 
processes of the dCas9-ED described above, make epigenetic remodeling by dCas9-ED 
problematic for screening purposes. 
On the other hand, the methylome modification allows for the first time through their targeted 
localization a functional, experimental evaluation of epigenetic regulatory elements and 
verifies bioinformatics predictions with a functional experiment such as we were able to 
conduct when targeting RGMA regulatory elements. The potentials for single gene 
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modulations are extensive, as the deeper level of transcriptomic modulation adds many 
possibilities to the research, allowing for much more complex genomic and regulatory 
functional evaluations.  
 
4.2.2 dCas9-ED mediated RGMA knock-down 
RGMA is a glycoprotein that exhibits a function as an axon guidance protein [200]. Knock-
down of this protein in cell culture models induced a binucleated or macronuclei phenotype 
([201]/ Mitosys ID: MCG_0007587), as detected in the different knock-down screens. In 2018, 
a study associated RGMA knock-down with high risk of luminal breast cancer and cancer 
progression [202, 203].  
The methylome modification induced down regulation of RGMA did show the strongest 
correlation with the siRNA-mediated gene knock-down in the 2D pre-screen as well as in a 
subsequent in-depth analysis using long-term light sheet live imaging of 3D spheroids (Table 
5). The evoked phenotype constitutes a reduced growth rate, elongated prophase and 
increased nuclei size resembling macronuclei formation described for this gene (Figure 24 / 
[201]).  
For RGMA, the induced phenotype was only achieved in sgRNA-dCas9-ED combinations that 
align with the knock-down prediction by bioinformatics analysis of the target site and the 
appropriate effector domain function. This results in the assumption that we were successful 
in RGMA knock-down by methylome modification of predicted correlated and anti-correlated 
regulatory CpGs. The localization of a large protein to the TSS on the other hand was similarly 
successful.  
The precise function and the effect of the loss of RGMA protein onto the cell cycle progression 
is not yet fully understood. We postulate that the RGMA knock-down phenotype was induced 
through the described altered utilization of the bone morphogenetic protein (BMP) type II 
receptors described by Xia and colleagues [204]. The authors describe a RGMA functions in 
the BMP pathway as co-receptor. A loss of the RGMA protein in the BMP signaling pathway 
can therefore have a dramatic effect on the intercellular interaction and consequently on the 
development of the spheroid model system through the BMP signaling.  
 
4.3 Comparison of siRNA and dCas9-ED as molecular regulator 
In total, we can conclude that in some cases the dCas9 fused with a methylome-modifying 
effector domain can provide the same effectivity as established knock-down methods and 
provides similar insight onto gene functionality as siRNA-mediated knock-down. But these 
results need to be carefully examined, replicated and the cause of the detected phenotype 
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needs to be validated. Comparison of the visual phenotype by light microscopy is insufficient 
to provide conclusive insight into gene function, mode of action and molecular pathways, but 
provides an exceptional assessment of the effect onto cellular processes and allows 
correlating gene function and cellular morphology. A combinatorial approach, such as 
combining RNAi with site directed positioning of epigenetic effector domains can validate and 
enrich knock-down experiments as well as insights into regulatory mechanisms.  
For studies analyzing the individual effect of a single CpG or a regulatory region in the context 
of its epigenetic regulatory properties, the different effector domains provide an exceptional 
opportunity to conduct functional analysis and challenge bioinformatic predictions. Especially 
for these defined functional experiments, the additional effort necessary to introduce a 
functional dCas9-ED in the cell is valid, but for knock-down high-content screens the best and 
simplest method of choice will remain RNAi.  
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5 Conclusion and Outlook 
In vitro cell culture systems are inevitably necessary models for human molecular biology 
research and translational medicine. 3D culture models, an innovative advancement from 2D 
cell culture, display more physiological in vivo characteristics, while posing significant 
challenges to novel and established analysis methods. These challenges have to be overcome 
to utilize the profound advantages of 3D cell culture models.  
The application of light sheet microscopy in this project to study 3D spheroid or organoid 
systems is highly beneficial due to the improved 3D imaging capabilities of the light sheet 
microscopes and the rapid acquisition capabilities provide high-throughput screening 
possibilities. Drawbacks of light sheet microscopy, mostly in data handling and image 
processing were addressed. High-content image processing pipelines, combined with state-
of-the art deep learning image classification are highly accurate and provide quantitative 
readout to evaluate treatment induced phenotype detection. The biggest advantage of the 
described screen was the individual analysis of single cells developing over time to spheroids 
and analyzing their properties.  
Furthermore, we developed and test two highly innovative methods to modify cellular 
properties and study them by the named 3D microscopy and image analysis. Conclusive 
insight on target gene function using the CRISPR-dCas9 based epigenetic modulation were 
not possible. The mode of action for the dCas9-ED requires in-depth evaluation of the 
underlying cellular processes and therefore require target site-specific evaluation. 
In the future, we expect to see a trend towards combining imaging and sequencing tools on a 
single cell level, where the phenotype and transcriptome are analyzed in a correlative manner. 
Additionally, deep learning image processing will be incorporated in many parts of the 
experimental process, from sample selection, to image acquisition, to microscopy control, to 
image analysis of raw data, and finally correlative analysis of sample properties and 
sequencing data, fusing visual and sequencing data into a single analysis step. A direct usage 
of deep learning classification of defined phenotypes such as macronuclei formation, ACE or 
tripolar cell division as well as other phenotypes was not feasible in this work as sufficient 
training data could not be provided, describing the difficulties arising from deep learning 
implementation into image analysis. Improvement in acquisition speed, imaging capabilities 
and integration of state-of-the-art illumination technologies such as structured illumination, will 
further increase throughput and image quality and resolution in HCS. With these technical 
improvements, a more detailed and extensive analysis will be possible by light sheet 
microscopy screening describing subcellular processes, structures and components in 
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unmatched detail. This will allow researchers to comprehensively study in a single experiment 
many different functional aspects in a highly quantitative fashion.  
Furthermore, we addressed the effectivity and capabilities of the novel, site-directed 
methylome-modifying effector domains and compared siRNA and regulatory CpG methylome 
modulation based gene knock-down phenotypes. Though being capable of inducing a gene 
knock-down, the effectivity and usability of the dCas9-ED does not rival that of conventional 
knock-down methods such as siRNA, yet. The long-term capabilities to induce lasting gene 
expression modulations are appealing, but need to be validated. We expect in the future an 
improvement of the site directed methylome modification, by improved protein and RNA 
delivery into the cell through reduced protein size and optimized delivery systems. 
Furthermore, we expect improved understanding and prediction of the dCas9 fused to different 
effector domains and its properties such as effectivity, off-targeting, long-term capabilities and 
application capabilities. The capability of the different effector domains to selectively modify 
epigenetic traits at defined genomic loci will provide in the future significant insights into the 
regulatory networks of the epigenome and the transcriptome as well as detailed descriptions 
of regulatory regions.  
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6 Materials and Methods 
6.1 High-content volumetric imaging screen utilizing advance light sheet 
3D microscopy 
6.1.1 Cell culture of MCF10A H2B-GFP 
MCF10A H2B-GFP cells [41] (P25 to P31) were cultured and passaged in 25 cm2 culture 
flasks (Greiner bio-one) in DMEM/F12 (ThermoFisher Scientific #11039) with supplements 
(5% horse serum, 10 µg/ml Insulin (Life Technologies), 20 ng/ml EGF, 0.5 mg/ml 
hydrocortisone and 100 ng/ml Cholera Toxin (Sigma)) under standard culture conditions (5% 
CO2 / 37 °C) and passaged with 0.05% Trypsin (Life Technologies) in 2D at 80-90% 
confluency every three to four days. 
 
6.1.2 Solid-phase reverse siRNA transfection 
Solid-phase reverse transfection siRNA transfection mix was prepared as described by Erfle 
et al. [181]. In short: 4.00 µl OptiMEM (ThermoFisher Scientific #51985026), containing 1.82 M 
trehalose dehydrate (Merck, #T9531), was added in a single well of a 384-well plate. Then 
2.50 µl Lipofectamine® RNAiMAX (ThermoFisher Scientific #13778075) transfection reagent 
and 5µl of a 5 µM siRNA solution were added and incubated for 5 min at room temperature to 
allow complex formation. Finally, 7.25 µl Collagen type IV solution (Merck #C5533) (1 mg/mL 
in ddH2O) was added and the transfection solution was gently mixed. The solution was diluted 
in 468.75 µl ddH2O of which 35 µl were transferred to a well of a 96-well plate. The plates 
were placed in a -20°C freezer for several hours, followed by a drying step (lyophilization or 
speed-vac), and were stored at room temperature until cell seeding.  
Trypsinated MCF10A H2B-GFP were diluted in growth medium to a density of 5x105 cells/ml. 
10’000 cells in 100 µl cell suspension were added to each well of the solid-phase reverse 
transfection mix. After five hours, cell medium was removed and cells were resuspended by 
directly adding 50 µl 0.25% Trypsin (Life Technologies #25200056) to each well.  
 
6.1.3 High-content cell spotting in Matrigel 
Mixing and spotting of cells into OneWell plate (Greiner bio-one CELLSTAR® OneWell Plate™ 
#670180) with Matrigel (Corning Matrigel Matrix) by an automated liquid handling robot from 
Hamilton Robotics following was conducted, following a customized protocol. In short: From 
each cell suspension transfected with individual siRNA, 60 isolated cells in 3 µl medium were 
mixed with 10 µl Matrigel. Subsequently each mixture was spotted eight times with a single 
spot volume of 0.2 µl in two columns by four rows array, giving a total of 320 spots in 40 
columns and eight rows array centred on the imaging plate. One sub-array of spots was always 
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dedicated for beads (ThermoFisher Scientific #7220) mixed with Matrigel, used for registration 
of the two acquired views. Positioning of each spot is identical with the positions of a standard 
1536-well plate. After 10 minutes at 37°C for Matrigel solidification culture/imaging medium 
was added and samples were incubated under standard culture conditions until imaging.  
 
6.1.4 diSPIM imaging 
Imaging was conducted with a dual-view inverted selective plane illumination microscope 
(diSPIM) as described by Kumar et al., 2014 [112]. The microscope was equipped with LMM5 
laser (Spectral Applied Research Laser Illumination Laser Merge Module 5) and AHF Quand 
Filterset (F59-405 / F73-410 / F57-406). Images were acquired by two water-cooled ORCA-
Flash4.0 Hamamatsu sCMOS cameras. Cooling was provided with Julabo F250 cooling 
circuit. Standard culture conditions were generated by (3i ECS2) and direct airflow over the 
SPIM head was minimized to avoid unnecessary vibrations. All imaging time lapse acquisitions 
were conducted with 320 µW laser power for 488 nm excitation wavelength (measured at the 
sample).  
 
6.1.5 Low resolution pre-screen 
Readjusting the fine alignment of the microscope was conducted shortly before the start of the 
acquisition with special attention to retain temperature within the microscope chamber. 
To detect each spheroid’s positions and select the spheroids to be imaged, we conducted a 
low resolution, fast stage-scan pre-screen. A grid of imaging positions was spanned across 
the imaging plate, each position placed at the center of one column of spots. As the automated 
spotting process resulted in spots with defined positions and sizes, we were able to repeatedly 
use the same grid of stage scan acquisition positions for every pre-screen. Potentially due to 
small manufacturing differences of the imagining plate, we solely needed to adjust the general 
Z-position off-set, underlining the robustness of our sample preparation process. Each position 
acquisition resulted in a X microscope-Stack of 1’200 slices with a step size of 5 µm and a pixel 
resolution of 0.648 µm/px and a field of view of 333 µm.  
The acquisition of the pre-screen took 31 minutes and produced 96’000 images. This pre-
screen data was subsequently analysed by a KNIME image processing workflow detecting 
the XYZ microscope position of each cell cluster, size and shape. Per spot we detected an average 
of 2.6 spheroids. From this data, a ranking of spheroids was conducted, based on their Z-
position, discarding small, flat and elongated cell clusters selecting for the spheroids with the 
maximal Z-coordinates. The KNIME workflow file can be found for review and further 
development on the Isilon server (\diSPIM_prescreen_stagescan_Pos_analysis.knwf).  
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The high positioning of the selected spheroid in the Matrigel spot ensured maximal image 
quality, as no additional cells obstructed the illumination and detection path. These 38 defined 
spheroids with individual treatment plus two positions with fluorescent beads that were 
essential for later image processing steps were imaged with the diSPIM microscope for 24 
hours at maximal temporal and spatial resolution for treatment evaluation. Incubation 
conditions in the microscope were improved to resemble as close as possible the standard 
culture conditions of an incubator.  
 
6.1.6 Position scan acquisition 
Imaging parameters for dual view synchronous piezo/slice scan (stack acquisition) were set, 
to acquire two stacks of 1024 px2 in XY image with the maximal camera resolution of 
0.1625 µm/px centered to the field of view of the camera and 260 slices in Z image with a slice 
interval of 0.5 µm starting with view A (right camera acquisition). Sample exposure was set to 
1.5 ms and the option for “Minimized Slice Period” enabled. The option for “Autofocus during 
acquisition” was enabled with the autofocus running on the registration position imaging beads 
every acquisition cycle with 40 slices acquired every 0.5 µm. The off-set was detected by with 
“Volath” script. 
Preselected positions copied from the KNIME analysis of the pre-screen were checked and if 
necessary manually corrected. An additional registration position was added as first and last 
position, imaging beads mixed in Matrigel.  
Due to the acquisition limitations of the microscope of minimal four to five seconds per position 
scan and stage repositioning, we imaged at an interval of five minutes for 24 hours, resulting 
in a total data volume of 10.06 terabytes (TB), which was stored locally. The high temporal 
resolution was essential for tracking of nuclei as they progressed through the cell cycle. 
Throughout time lapse acquisition, we did not need to adjust for any position off-set introduced 
by deformation of the matrigel or external influences as samples remained almost exclusively 
in the FOV.  
 
6.1.7 Image processing (hSPIM) 
Raw data was processed by a custom software named “hSPIM”, designed specifically to the 
acquisition geometry of the di-SPIM and the separate acquired registration position imaging 
beads in 3D. In short: The registration matrix of the two views is detected for each time point 
of the screen by registration of beads in 3D. Additionally, the PSF is extracted. This registration 
matrix and PSF are stored and used for registration and deconvolution of all other acquired 
positions of this time point. Furthermore, the software performs a segmentation of the nuclei, 
from which different geometrical and textural features are extracted for each segment. 
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Deconvolved fusion images and segment images as well as segment and feature table are 
stored and were used for further image analysis.  
In addition, further functions are implemented into the hSPIM software. These can enable the 
user to directly visualize in 3D a registered and deconvolved snap image or to store a view 
angle and export a 3D movie of a single position.  
 
6.1.8 High-content KNIME analysis workflow 
Following the raw image processing, we have developed a workflow to analyze key cellular 
and global properties of each spheroid throughout the acquired time lapse by image analysis.  
XYZ microscope displacement: By tracking the positions of single beats over time in the beat 
sample we could detect the global offset in all dimensions of the microscope introduced 
through fine displacements of the imaging plate or component expansion of the di-SPIM 
components.  
Cell phase nuclei classification: For a precise nuclei classification, we used a CNN, trained 
with a selection of manually classified images by means of 3D-2D plane DL classification 
described in 3.2.5. The CNN calculated the probability for each of the four distinguishable cell 
cycle phases for each XY, XZ and YZ slices: Interphase, pro- and prometaphase, metaphase, 
anaphase. The class with the highest sum in likelihood for each segment was selected as 
defining class for this nucleus at this time point.  
Clustering of segments into spheroids: To segregate segments from two spheroids 
acquired at a single imaging position into individual spheroid clusters, we analyzed the 
geometric distance of each segment to all others and clustered accordingly.  
Spheroid size: The clustering enabled us to combine all segments of one spheroid for an 
image based size calculation.  
Geometric nuclei class features: In the global context of the single spheroid we analyzed 
the single nuclei size, the intensity, the position of the segment from the center of the spheroid 
and the predicted class, over time. 
Nuclei migration speed: By tracking the position of each segment over time, we also 
analyzed the median migration speed of all cells in each spheroid. 
Time lapse movie: For individual evaluation, we exported the maximum projected time lapse 
movie of each position including cell cycle classification and spheroid hull. 
 
The KNIME workflow file can be found for review and further development on the Isilon server 
(\diSPIM_phenotype_screen_analysis_3D_spheroids.knwf) as well as the template folder 
structure for hSPIM- and KNIME analysis workflow output 
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(\TLXXXX_S_hSPIM_Output_Template) with XXXX being place holders for the screen 
number.  
 
6.1.9 Spheroid feature evaluation 
Selected image features as quantified by the KNIME workflow (Supplementary Tables 2) were 
subsequently subjected to further quantitative analysis in R. Additional quantitative features 
such as cell volume (estimated as the ratio of spheroid volume to nuclei number) and average 
nuclei size in different cell phases were additionally computed from the quantified list of 
features. The fraction of cells detected in different cell cycle phases was averaged across all 
time points.  
To calculate instantaneous spheroid growth rates from nuclei numbers, the number of nuclei 
over time was smoothed using the lowess function with parameters f=1/3, iter=3L, delta=0.01 
* diff(range(NrCells[1:n.rows[[pos]],pos])), and differentiated using the diff function.  
 
All feature measurements from all plates were combined into one matrix, centered by 
subtracting the column means from their corresponding columns, and scaled by dividing the 
centered columns their standard deviations. As mechanical plate drift resulted in spheroids 
lying partially outside the field of view in the case of plate 00941, affected features (nuclei and 
spheroid growth rate, compactness, convexity, sphericity, spheroid volume and cell volume) 
were excluded for this plate. 
 
To identify clusters of siRNAs causing similar phenotypes, rank-based clustering and tSNE 
embedding were performed using the rank, dist, hclust and Rtsne functions. Heatmaps were 
created using the heatmap.2 function from the gplots package or the aheatmap function from 
the NMF package. t-tests for statistical comparisons were performed using the t.test function  
 
6.2 dCas9-effector domains 
6.2.1 Construct synthesis 
All three used dCas-ED constructs (C49 – dCas9; C54 – DNMTA3-dCas9; C57 – TET1-
dCas9) were assembled by Gibson Cloning (NEB #E2611) following manufacturer guidelines. 
Source constructs were obtained from AddGene: dCas9 [85], DNMT3a [171], TET1 [205]. 
Linker (GGGGS), NLS (PKKKRKV) and M2-Flag (DYKDHDG) DNA sequences as well as 
adapter primers were ordered from Eurofins Genomics. Successful cloning was assessed by 
sequencing by GATC Biotech AG following general guidelines, western blot (M2-flag) and 
expression in HEK293 cells detected by immunostaining (6.2.5).  
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Plasmid maps and construct components can be reviewed here 
(\EpiToolConstructs_synthesis) 
 
construct effector domain description 
C49 non pcDNA_Tag_NLS_dCas_linker_STOP 
C54 DNMT3a C54_pcDNA_Tag_NLS_dCas_Linker_Dnmt3a 
C57 TET1 C57_pcDNA_Tag_NLS_dCas_Linker_Tet1 
 
 
6.2.2 Stable dCas9-ED expression in HEK293 cell line 
5 x 105 HEK293 cells were transfected with 5 µg plasmid DNA of the different dCas9-ED 
constructs (C49, C54, C57) with Lipofectamin 2000 (Invitrogen) following manufacturer 
guidelines. 48 hours post dCas9-ED plasmid transfection, transfected cells were selected for 
by addition of G418 (Geneticin) selection antibiotic to the culture medium at a concentration 
of 500 µg / ml. Stock cultures were frozen after four passages under constant G418 selection 
resulting in stable dCas9-ED expressing cell lines. 
 
6.2.3 Single guide RNA synthesis 
SgRNA expression plasmids were designed and synthesized following the recommended 
SAM target sgRNA cloning protocol by Konermann and colleagues [194]. In short: the 
sgRNA(MS2) cloning backbone (AddGene: #61424) was digested with BbsI. Oligos 
representing the sgRNA target site with 20 bases in sense (Os) with an CACCG overhang and 
anti-sense (Oas) with an AAAC overhang were ordered from Eurofins and annealed. For 
genome reference, we used the UCSC Genome Browser on Human Feb. 2009 
(GRCh37/hg19). Backbone and sgRNA defining insert were joined by a Golden Gate reaction. 
The resulting plasmid was expanded by bacterial transformation and assessed by sequencing. 
 
6.2.4 Stable dCas9-ED cell lines sgRNA transfection 
The HEK293 cells were transfected with the different sgRNA constructs by solid-phase 
reverse transfection as described in section 6.1.2, with Lipofectamine RNAiMAX being 
replaced by Lipofectamin 2000 (Invitrogen #11668027).  
 
6.2.5 Immunostaining of HEK293 cells for DNA, sgRNA and dCas9-ED 
HEK293 cells were fixed and stained at different time points between 3 and 9 days after 
transfection for the two components of the functional dCas9-ED by IF staining. Cells were 
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fixed by 4% PFA (Sigma-Aldrich #F8775) for 10 minutes in PBS with 0.5 % triton x-100 and 
blocked subsequently by 1% goat serum in PBS applied overnight. We used the mouse anti-
Flag M2 monoclonal antibody from Sigma (#F1804) as primary and the goat anti-mouse Alexa 
568 secondary antibody from Invitrogen (#A11004) to label the dCas9-ED in red. To detect 
the successful transfection with the sgRNA plasmid we applied rabbit anti-GFP monoclonal 
antibody from Cell Signaling (#2956) as primary and goat anti-rabbit Alexa 488 from Molecular 
Probes (#A11034) as secondary antibody. The DNA was stained by DAPI. Careful 
intermediate washes with PBS removed excess antibodies.  
 
6.2.6 Confocal imaging of IF stained epigenome targeted HEK293 cells 
Confocal imaging was conducted using the Zeiss LSM 780 under the control of 
AutofocusScreen macro (http://www.ellenberg.embl.de/apps/AFS/, 24.02.2016) acquiring 25 
Z-stacks per well with each comprising five slices per dCas9-ED-sgRNA combination (one 
dCas9-ED / one target gene). Each stack was acquired with a bright field image additionally 
to the DAPI (405 nm), sgRNA (488 nm) and dCas9-ED (568 nm) channel.  
 
6.2.7 Image analysis of dCas9-ED HEK293 cells and phenotype evaluation 
Raw HEK293 images of each sgRNA-dCas9-ED combinations were smoothened by Gaussian 
convolution and single nuclei were segmented by Otsu thresholding. Single segments were 
further processed and spitted if necessary by segment erosion. Single nuclei were classified 
by a DNN into cell cycle stages (inter-, pro-, met-, anaphase) as well as significant phenotypes 
(macronuclei and apoptotic condensed DNA). Additionally, the transfection state of the cell 
was evaluated by the presence of an dCas9-ED (M2-flag) and the sgRNA (GFP). Cells with 
both dCas9-ED components present were labeled double positive. KNIME workflow can be 
found here: (\EpiTool_confocal_nuclei_classification.knwf)  
Detected classes were further evaluated in comparison to non-targeted sgRNA transfected 
dCas9-ED cell lines as well as to non-transfected cells. All acquired time points (3, 5, 7 days 
post transfection) were combined during analysis. Cells with a significant increase (> 1.5 ratio) 
of a class between control cells were highlighted. KNIME workflow can be found here: 
(\EpiTool_Class_quantitative_analysis.knwf) 
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6.3 Materials 
6.3.1 Hardware 
6.3.1.1 Workstation 
hardware supplier description 
CPU Intel i9-7980XE 
GPU NVIDIA Titan xp 12 GB  
Hard drive (RAID0) WD WD-Red 8 TB 
RAM ECC 64 GByte DDR-4 PC2400 
Motherboard ASRock X299 Taichi  
Controller Intel SATA Controller, 10x 6 Gbit/s 
Hard drive Samsung 1 TB 960 Pro 
 
6.3.1.2 ASI diSPIM hardware 
hardware supplier description / number 
camera cooling Julabo F250 
quand filterset AHF 
F59-405 
F73-410 
F57-406 
sCMOS cameras Hamamatsu ORCA-Flash4.0 
laser Spectral Applied Research Laser Merge Module 5 (LMM5) 
 
6.3.2 Software and workflows 
6.3.2.1 Software 
name version description 
KNIME 3.5.5 Konstanz Information Miner 
hSPIM 1.0 diSPIM raw image processing tool 
MicroManager 1.4 microscope control software 
diSPIM plugin NB_20180116 nightly build MicroManager diSPIM controller plugin 
 
6.3.2.2 KNIME workflows 
name folder 
diSPIM_prescreen_stagescan_Pos_analysis Group\Bjoern_Isilon\BjoernEismann_PhD_Thesis_Data 
diSPIM_phenotype_screen_analysis_3D_spheroids Group\Bjoern_Isilon\BjoernEismann_PhD_Thesis_Data 
EpiTool_confocal_nuclei_classification Group\Bjoern_Isilon\BjoernEismann_PhD_Thesis_Data 
EpiTool_Class_quantitative_analysis Group\Bjoern_Isilon\BjoernEismann_PhD_Thesis_Data 
 
  85 
6.3.2.3 Haralick features 
Haralick 
feature discription 
Haralick 
feature discription 
F1 contrast F8 sum entropy 
F2 angular second moment  F9 entropy 
F3 correlation F10 difference variance 
F4 sum of squares: variance F11 difference entropy 
F5 inverse difference moment F12 measure of correlation I 
F6 sum average F13 measure of correlation II 
F7 sum variance   
 
6.3.3 Source constructs  
construct source description / number 
#46911 AddGene Gilbert_pHR-SFFV-dCas [85] 
#71666 AddGene pdCas9-DNMT3A-EGFP [171] 
#49792 AddGene FH-TET1-pEF [205] 
#61424 AddGene sgRNA(MS2) cloning backbone 
 
6.3.4 Antibodies 
description source number description 
anti-Flag® M2 Sigma F1804 primary mouse anti Flag M2 monoclonal antibody 
anti-GFP Cell signaling 2956 primary rabbit anti GFP monoclonal antibody 
Anti-rabbit Alexa 488 Molecular Probes A11034 fluorescent secondary goat anti rabbit antibody  
Anti-mouse Alexa 568 Invitrogen A11004 fluorescent secondary goat anti mouse antibody 
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6.3.5 Consumables and solutions 
description supplier product number 
beads: PS-Speck™ Microscope  ThermoFisher Scientific P7220 
Cell Culture Plate, 96-Well Eppendorf 0030730119 
CELLSTAR® OneWell Plate™ Greiner bio-one 670180 
Cholera toxin Sigma-Aldrich (Merck)  
Collagen type IV solution Merck C5533 
culture flasks (25cm2) greiner bio-one  
DAPI Sigma-Aldrich (Merck) D9542 
DMEM/F12  ThermoFisher Scientific 11039 
G418 (Geneticin) Sigma-Aldrich (Merck) 4727878001 
Gibson Assembly Master Mix NEB E2611 
Insulin Life Technologies  
Lipofectamin 2000 Invitrogen 11668027 
Lipofectamine® RNAiMAX  ThermoFisher Scientific 13778075 
Matrigel Corning 354248 
OptiMEM ThermoFisher Scientific 51985026 
PCR plate, 96 well Kisker G060  
trehalose dehydrate Merck T9531 
trypsin Life Technologies 25200056 
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6.3.6 siRNA – Ambion 
gene name siRNA ID 1 siRNA ID 2 
ATOH8 s39645 s39643 
AURKA s196 s197 
BUD31 s17010 s17009 
CDC6 s2744 s2746 
CDCA5 s41424 s41425 
CEP85 s34959 s34961 
CTSB s3738 s3739 
DSE s26749 s26750 
EME1 s44946 s44945 
ESYT2 s33138 s33136 
F11R s27152 s27151 
FOXM1 s5250 s5249 
LGR4 s30840 s229314 
LHFP s19847 s19848 
LMNB2 s39477 s39476 
LRP1 s8278 s8280 
MAP7 s17263 s17262 
MEIS2 s8666 s8664 
MYC s9130 s9131 
PLK1 s448 s450 
PRC1 s17268 s17269 
RAN s11769 s11768 
RBBP4 s55169 s56872 
RGMA s32498 s32500 
TCF7 s13877 s13878 
TOP2a s14307 s14308 
TUFT1 s14510 s14509 
WBP1 s24095 s225969 
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7.3 Units 
 abbreviation unit 
weights	
pg picogram 
ng nanogram 
µg microgram 
mg milligram 
volume	
nl nanoliter 
µl microliter 
ml milliliter 
distance	
nm nanometer 
µm micrometer 
mm millimeter 
cm centimeter 
time	
sec seconds 
min minutes 
h hours 
rotation	force	
rpm revolutions per minute 
g relative centrifugal force 
temperature	
°C degree celsius 
RT room temperature (~21 °C) 
optics	
λ wavelength 
NA numerical aperature 
data	
GB gigabyte 
TB terabyte 
MB megabyte 
KB kilobyte 
 
  
  91 
7.4 Abbreviations   
2D two-dimensional 
3D three-dimensional 
ASI Applied Scientific Instrumentation 
bNGS bulk next-generation sequencing 
bp base pairs 
BSA bovine serum albumine 
CLSM confocal laser scanning microscopy 
CNNs convolutional neuronal networks 
CO2 carbon dioxide  
CpG cytosine guanine dinucleotide 
CRISPR clustered regularly interspaced short palindromic repeats 
CSC cancer stem cell 
diSPIM dual inverted single plane illumination light sheet microscopy 
DL deep learning 
DNA  deoxyribonucleic acid 
DNMT DNA methyltransferases 
DNN deep neuronal networks 
dNTP deoxynucleotide triphosphate 
dps days post seeding 
ECM extracellular matrix 
ED effector domains 
EGF epidermal growth factor 
FEP fluorinated ethylene propylene 
FOI field of interest 
FOV field of view 
GFP green fluorescent protein 
HC  high-content 
HCS high-content screen 
HEK 293 human embryonic kidney cell line 293 
HeLa Henrietta Lacks cell line 
HT  high-throughput 
HTS high-throughput screen 
IF immunofluorescence 
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KNIME Konstanz Information Miner 
LSFM Light Sheet Fluorescence Microscopy  
me methylation 
MVR multi view reconstruction 
NA numerical aperture 
NB nightly built 
NLS nuclear localization sequence 
OPFOS orthogonal-plane fluorescence optical sectioning  
OTP one-touch-pipeline 
P Passage 
PBS phosphate buffered saline 
PBS phosphate-buffered saline 
PDTXs patient-derived tumor xenografts 
RF random forest 
RI refractive index 
RNA  ribonucleic acid 
RT room temperature 
sCMOS scientific complementary metal-oxide semiconductor 
SCS single cell sequencing 
SDM Spinning-disk (Nipkow disk) confocal microscopes 
sgRNA single guide RNA 
SPIM selective plane illumination microscopy 
ssOPM stage-scanning OPM approach 
SSA stage scan acquisition 
SyncA synchronous piezp/slice acquisition  
TALEN Transcription Activator-Like Effector Nuclease 
TET1 Ten-eleven translocation methylcytosine dioxygenase 1 
TP time point 
tSNE t-distributed stochastic neighbor embedding  
TSS transcription start site 
ZF zinc finger DNA binding proteins 
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9 Supplementary Data 
9.1 Supplementary Figures 
 
Supplementary Figure 1 – Matrigel displacement 
Comparison of the positioning of beads immersed in matrigel at the beginning of the acquisition (TP0 - green) and 
at the last time point (TP298 - red) 24 hours later. Displacement was registered to the center of the image.  
 
 
 
Supplementary Figure 2 – Transfer of registration matrix and PSF between positions 
A key feature of the workflow is the separation of beads and sample. Position 0 and 39 of each acquisition were 
dedicated to beads mixed with Matrigel. When the registration matrix and PSF of both bead positions (Pos0 and 
Pos39) are applied to Pos0 for image processing, the shift in the resulting image is less than a pixel (< 0.325 µm) 
(scale bar = 50 µm).  
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Supplementary Figure 3 – VGG-based convolutional neural network 
Used convolutional neural network for nuclei cell cycle stage classification, comprised of convolutional layers and 
maxpooling layers. The output is combined by two fully-connected layers.  
 
 
 
Supplementary Figure 4 – maximum projection DL classification 
Utilizing the maximum projection of a nuclei segment for a more convenient and less computational costly cell 
phase classification results in a significant decreased accuracy of only 75%.  
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Supplementary Figure 5 – dying cell misclassification 
Cell undergoing apoptosis are classified as prophase (green) and anaphase (red). Sample: Aurora kinase A knock-
down spheroid at time point 1 to 26 of HCS at five minutes’ interval.  
  109 
 
Supplementary Figure 6 – Ratio of cell phase upon knock-down 
Bar plot for each all knock-down samples depicting the ratio of the four classified cell cycle stages.  
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Supplementary Figure 7 – Violin plot of class distribution within the spheroid 
Summary of the class distribution within the spheroid for all samples depicted by a violin plot.   
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9.2 Supplementary Tables 
Supplementary Tables 1 - Selected target genes 
Target genes were selected due to defined characteristics. They needed to be associated with the cell cyclce. The 
selected target genes also needed to display an expression regulation by either correlated or anti-correlated CpG 
methylation level with high Pearson correlation value (R).  
target	
gene	 name	
Ambion	
siRNA#	
regulatory	
CpG	
CpG	properties	
(expression/-
me)	
Ravg	=	
ATOH8	 Protein	atonal	homolog	8	 s39645	/	s39643	 1	 anti-correlated	 0.52	
AURKA	 Aurora	kinase	A	 s196	/	s197	 2	
correlated	/	
anti-correlated	 0.52	
BUD31	 Protein	BUD31	homolog	 s17010	/	s17009	 1	 correlated	 0.45	
CDC6	 Cell	division	control	protein	6	 s2744	/	s2746	 2	 anti-correlated	 0.65	
CDCA5	 Sororin	 s41424	/	s41425	 6	 correlated	 0.70	
CEP85	 Centrosomal	protein	of	85	kDa	 s34959	/	s34961	 5	
correlated	/	
anti-correlated	 0.64	
CTSB	 Cathepsin	B	 s3738	/	s3739	 1	 anti-correlated	 0.53	
DSE	 Dermatan	Sulfate	Epimerase	 s26749	/	s26750	 1	 anti-correlated	 0.54	
EME1	 Essential	Meiotic	Structure-Specific	Endonuclease	1	
s44946	/	
s44945	 1	 correlated	 0.66	
ESYT2	 Extended	synaptotagmin-2	 s33138	/	s33136	 2	 anti-correlated	 0.75	
F11R	 F11	Receptor	 s27152	/	s27151	 6	 anti-correlated	 0.55	
FOXM1	 Forkhead	Box	M1	 s5250	/	s5249	 1	 correlated	 0.68	
LGR4	 Leucine-Rich	Repeat	G.Prot-Coupled	Receptor	4	
s30840	/	
s229314	 1	 anti-correlated	 0.61	
LHFP	 Lipoma	HMGIC	Fusion	Partner	 s19847	/	s19848	 1	 correlated	 0.57	
LMNB2	 Lamin	B2	 s39477	/	s39476	 1	 anti-correlated	 0.60	
LRP1	 LDL	Receptor	Related	Protein	1	 s8278	/	s8280	 4	 anti-correlated	 0.70	
MAP7	 Ensconsin	 s17263	/	s17262	 2	 correlated	 0.67	
MEIS2	 Meis	Homeobox	2	 s8666	/	s8664	 7	
correlated	/	
anti-correlated	 0.57	
MYC	 Myc	proto-oncogene	protein	 s9130	/	s9131	 2	 anti-correlated	 0.68	
PLK1	 Polo-like	kinase	1	 s448	/	s450	 4	 correlated	 0.64	
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PRC1	 Protein	regulator	of	cytokinesis	1	 s17268	/	s17269	 1	 anti-correlated	 0.73	
RAN	 GTP-binding	nuclear	protein	Ran	 s11769	/	s11768	 1	 anti-correlated	 0.60	
RBBP4	 Histone-binding	protein	RBBP4	 s55169	/	s56872	 1	 anti-correlated	 0.57	
RGMA	 Repulsive	Guidance	Molecule	Family	Member	A	
s32498	/	
s32500	 7	
correlated	/	
anti-correlated	 0.70	
TCF7	 Transcription	factor	7	 s13877	/	s13878	 2	 anti-correlated	 0.71	
TOP2A	 Topoisomerase	II	Alpha	 s14307	/	s14308	 2	 correlated	 0.66	
TUFT1	 Tuftelin	 s14510	/	s14509	 2	 anti-correlated	 0.59	
WBP1	 WW	Domain	Binding	Protein	1	 s24095	/	s225969	 1	 correlated	 0.52	
 
 
Supplementary Tables 2 – 23 factors describing spheroid phenotype 
A total of 23 factors were calculated to define the phenotype of the spheroid throughout the time lapse. These 
factors describe properties of the whole spheroid, spheroid development and single nuclei features throughout the 
twenty-four hour time laps.  
factor	 name	 Description	
global	or	
nuclei	
feature	
1	 spheroid	growth	rate	(nuclei)	 increase	of	nuclei	count	over	the	course	of	the	time	lapse	 global	
2	 prophase	ratio	 fraction	of	nuclei	classified	as	“prophase”	from	all	nuclei		 nuclei	
3	 metaphase	ratio	 fraction	of	nuclei	classified	as	“metaphase”	from	all	nuclei		 nuclei	
4	 anaphase	ratio	 fraction	of	nuclei	classified	as	“anaphase”	from	all	nuclei		 nuclei	
5	 avg.	cell	volume	 the	nuclei	size	in	voxel	number	of	all	nuclei	in	all	cell	phases	 global	
6	 prophase	segment	volume	 the	nuclei	size	in	voxel	number	of	all	nuclei	classified	as	“prophase”	 nuclei	
7	 metaphase	segment	volume	 the	nuclei	size	in	voxel	number	of	all	nuclei	classified	as	“metaphase”	 nuclei	
8	 anaphase	segment	volume	 the	nuclei	size	in	voxel	number	of	all	nuclei	classified	as	“anaphase”	 nuclei	
9	 interphase	segment	volume	 the	nuclei	size	in	voxel	number	of	all	nuclei	classified	as	“interphase”	 nuclei	
10	 spheroid	volume	 the	spheroids	volume	in	voxel	throughout	the	time	lapse	 global	
11	 avg.	segment	volume	 the	nuclei	size	in	voxel	number	of	all	nuclei	in	all	cell	phases	 global	
  113 
12	 spheroid	growth	rate	(volume)	 increase	in	volume	of	the	spheroid	hull	throughout	the	time	lapse	 global	
13	 spheroid	compactness	 factor	describing	the	volume	in	relation	to	the	largest	extend	 global	
14	 convexity	 factor	describing	the	volume	in	relation	to	the	surface	 global	
15	 nuclei	migration	speed	 average	movement	of	all	nuclei	in	3D	space	in	pixel	per	time	point		 global	
16	 interphase	transition	duration	 average	duration	of	a	nuclei	in	“interphase”	 nuclei	
17	 prophase	transition	duration	 average	duration	of	a	nuclei	in	“prophase”	 nuclei	
18	 metaphase	transition	duration	 average	duration	of	a	nuclei	in	“metaphase”	 nuclei	
19	 anaphase	transition	duration	 average	duration	of	a	nuclei	in	“anaphase”	 nuclei	
20	 total	number	cell	cycle	transitions	 total	number	of	biological	possible	cell	cycle	phase	transitions		 global	
21	 normal	/	abnormal	transition	 faction	of	cell	cycle	phase	transitions,	that	are	biological	impossible	 global	
22	 spheroid	roundness	 factor	describing	shape	of	spheroid	 global	
23	 size	/	spheroid	roundness	ratio	 ratio	of	size	and	roundness	 global	
 
 
Supplementary Tables 3 – Number of normal and abnormal transition detected 
target	gene	 normal	transition	 abnormal	transition	 ratio	 n	=	spheroids	
NC	 146,101	 1,380	 0.99	 12	
EMPTY	 192,450	 1637	 0.99	 12	
INCENP	 4,193	 317	 0.92	 12	
ATOH8	 39,421	 514	 0.99	 6	
AURKA	 35,123	 454	 0.99	 6	
BUD31	 33,567	 368	 0.99	 6	
CDC6	 56,024	 1,476	 0.97	 6	
CDCA5	 31,556	 494	 0.98	 6	
CEP85	 23,590	 520	 0.98	 6	
CTSB	 49,919	 1,317	 0.97	 6	
DSE	 24,199	 578	 0.98	 6	
EME1	 21,214	 362	 0.98	 6	
ESYT2	 39,147	 873	 0.98	 6	
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F11R	 63,331	 701	 0.99	 6	
FOXM1	 67,996	 820	 0.99	 6	
LGR4	 47,385	 577	 0.99	 6	
LHFP	 42,949	 630	 0.99	 6	
LMNB2	 67,367	 752	 0.99	 6	
LRP1	 38,655	 571	 0.99	 6	
MAP7	 28,768	 525	 0.98	 6	
MEIS2	 31,524	 1,326	 0.96	 6	
MYC	 42,240	 703	 0.98	 6	
PLK1	 21,475	 450	 0.98	 12	
PRC1	 12,712	 205	 0.98	 6	
RAN	 35,225	 251	 0.99	 6	
RBBP4	 62,204	 465	 0.99	 6	
RGMA	 56,631	 792	 0.99	 6	
TCF7	 53,754	 573	 0.99	 6	
TOP2A	 43,639	 484	 0.99	 6	
TUFT1	 73,423	 782	 0.99	 6	
WBP1	 51,438	 784	 0.98	 6	
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